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ABSTRACT
The use of the ketone biotin - benzophenone-biotin hydrazide system for detecting the
formation of cyan fluorescent protein and NF-kappaB p50 dimers was assessed. A series
of benzophenone-based probes were synthesized and tested for photocrosslinking activity
to investigate the efficiency of photocrosslinking in these systems.
Three series of small molecule probes were synthesized for the selection of ribozymes
from a random sequence pool. Solid-phase immobilized fluorescein and fluorescein
phosphates were synthesized for the indirect selection of a fluorescein phosphatase
ribozyme. A corresponding thiophosphate analog was created for the in-gel selection of a
thiophosphatase ribozyme via APM-PAGE. Finally, a series of fluorescein-nucleoside
phosphate conjugates was designed and synthesized for use in the solution phase
preparation of a fluorogenic ribozyme substrate, and later immobilization of this substrate
on a silyl resin for direct ribozyme selection.
Thesis Supervisor: Alice Ting
Title: Associate Professor of Chemistry
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Chapter 1: Detection of p50 dimerization by photocrosslinking
Introduction
Protein-protein interactions play a critical role in the function of a cell. A vast
network of interactions mediates critical functions such as signal transduction, gene
expression, and intracellular transport to name a few. Study of this network, is essential
for understanding normal cellular function and gaining insight to correct the imbalances
that lead to disease states. A critical step in exploring this intricate web is the
identification of interacting factors.
A variety of methods has been developed for studying interactions between
proteins. The use of immunoprecipitation is a well-accepted method for detecting these
interactions'. While quite reliable, the method requires the generation of multiple
antibodies and requires a large number of controls to rule out false positives.
Furthermore, this method yields data that represents an average over a cell population
while sacrificing both spatial and temporal information. Alternatively,
immunofluorescence staining allows for detection of the protein with retention of spatial
information, but can only demonstrate protein co-localization within 200-500 nm24 .
Protein complementation and fluorescence resonance energy transfer (FRET)
assays provide higher spatial resolution of the protein interactions. Examples of protein
complementation systems include the yeast 2-hybrid and split-GFP methods. The yeast 2-
hybrid method takes advantage of fusions to transcription factor fragments to modulate
the expression of a reporter. The DNA binding domain and transcriptional activator
domain are fused to the two proteins suspected of interacting. If they interact, the two
domains are brought together and trigger the expression of the reporter. However, this
method gives both false positives or negatives when the transcription factor fragments
induce interaction or the fusions prevent interaction of the fragments respectively.
Furthermore, the system is restricted to proteins localized within the nucleus. 1 The split
GFP system, in which each protein of interest is fused to a fragment of green fluorescent
protein (GFP), allows for detection outside the nucleus by using the recombination and
folding of GFP fragments to form a fluorophore ' 5. Unfortunately, the monitoring of
transient interactions is hampered by the irreversible nature of this folding event'. Like
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the yeast 2-hybrid approach, it is also possible for the GFP fragments to induce
interaction, thereby creating false positives. FRET relies on the proximity of a donor and
acceptor fluorophore to produce a signal. As the intensity of the FRET signal is
proportional to the distance between the donor and acceptor6 , the system can be used to
detect the interaction of two proteins fused to the fluorophores. All three approaches use
rather large protein labels, and could potentially alter protein localization and behavior,
and hamper normal interaction of the fused proteins5' 7. The use of a smaller tag would
reduce the chances of disrupting wild-type behavior. Small molecule labels, such as
crosslinking moieties capable of trapping interacting proteins, could replace these
systems, but need a method for directing them in a site-specific manner.
Several methodologies are available for site-specific labeling of proteins using
small peptide tags. A Texas Red binding peptide was selected from a phage library to
result in tags less than 50 amino acids capable of fluorescent protein labelings. The His6 -
Ni-NTA interaction has also been used to fluorescently label His6-tagged proteins9.
Another six amino acid tag containing a CCXXCC motif allows for the binding of
biarsenical fluorophoresl°. While an improvement over current labeling strategies, all
these methods lack covalent attachment between the protein and the label, which can
result in loss of signal due to dissociation. A more optimal solution should feature
covalent linkage to the protein.
Biotin ligase (BirA) covalently labels proteins bearing a 15 amino acid tag, the
acceptor peptide (AP). Our lab recently demonstrated the labeling of proteins in vitro as
well as on cell surfaces with a ketone analog of biotin (KB)". Ketone biotin can then be
labeled with hydrazide probes including the bi-functional probe BPBio-hydrazide that
bears a benzophenone (BP) group for photocrosslinking and biotin (Bio) for product
capture and detection. The utility of this methodology in labeling proteins site-selectively
has been demonstrated, but its second function in photo cross-linking interacting proteins
has yet to be shown. This would provide a way to 'lock-down' proteins interacting with
the tagged protein for later identification. To demonstrate this function, a well-
characterized protein-protein interaction was chosen.
The NF-KB family of transcription factors serves a wide variety of roles in
healthy and diseased states. Even though they are most commonly known for their roles
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in the regulation of elements of immunity and inflammation12-15, excessive activation of
these factors has also been linked to cancer1 6 and chronic inflammatory diseases17.
Normally masked by inhibitory proteins in the cytosol, a variety of stimuli can trigger
activation and cause NF-KB to dimerize and translocate to the nucleus where they may
regulate gene expression. Among all the NF-KB factors, we chose p50 based on the
availability of the crystal structure of the interacting proteins'3 ' 18 as well as the binding
affinities for the dimerization event under a variety of conditions19' 20. These data made
p50 a good choice for the demonstration of the photo cross-linking potential of the KB-
BPBio labeling methodology.
Results
Cyan fluorescent protein (CFP) bearing a C-terminal acceptor peptide (CFP-AP)
as well as the CFP mutant bearing a lysine to alanine mutation in the AP (CFP-Ala) was
recombinantly expressed from pRSETB. The p50-AP gene was amplified by PCR from
the p50 protein in pET15b'8 with primers to introduce an N-terminal BamHI site and a C-
terminal AP tag, stop codon, and EcoRI site. The resulting PCR product was gel purified
and ligated into a BamHI / EcoRI / CIP digest of pRSETB. The ligation product was
transformed into DH5a, and clones selected for sequencing. The p50-Ala mutant was
obtained from p50-AP by site-directed mutagenesis and confirmed by sequencing.
Expression of all proteins was conducted in E. coli strains BL21(DE3) or JM 109.
CFP-AP and CFP-Ala in pRSETB expressed well in both strains as did recombinant
biotin ligase (BirA) in cloned pBTac. All proteins were purified by a Ni-NTA column. In
contrast, only low levels of expression were found for both p50 proteins in pRSETB.
Attempts to optimize induction time, IPTG concentration, bacterial strain, growth
medium, and temperature did not improve protein yield. The wild-type protein, which
was cloned in pET 15b, was found to express well. Sufficient protein was obtained from
multiple preparations to conduct experiments, and all AP-tagged proteins used herein are
from pRSETB vectors. However, a means to improve protein yield for later work was
still sought.
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A search of the literature found that most successful expressions of p50 proteins
in vitro had been obtained when p50 was cloned in pET vectors. Thus, the gene was
transferred to a new vector. pET2 lb was chosen as it contained both BamHI and EcoRI
sites in the correct orientation as well as ampicillin resistance. Use of this plasmid,
however, changed the position of the His6-tag used for Ni-NTA purification from N-
terminal to C-terminal and required removal of the C-terminal stop codon used in
pRSETB. Transfer of the gene was completed by BamHI / EcoRI double digest of both
vectors, and gel purification of both insert and vector, followed by ligation. Plasmids
were confirmed by sequencing and site-directed mutagenesis was performed to remove
the stop codon and bring the His 6-tag in frame. Following mutagenesis, the new plasmids
were again confirmed by sequencing.
As E. coli normally express their own BirA, AP-tagged proteins are expressed
with a significant level of pre-biotinylation. This pre-biotinylated material must be
removed to avoid false positives during biotin detection. Streptavidin-agarose was used to
capture biotinylated protein following Ni-NTA purification to yield purified AP-tagged
proteins. The efficiency of debiotinylation and integrity of the AP tag was tested using a
biotinylation assay.
BirA also required processing after purification as the biotin-AMP ester is
retained in the active site and co-purifies with BirA. This is easily removed by allowing
the enzyme to catalyze its reaction in the presence of excess synthetic AP, followed by
repurification by Ni-NTA column. A more rigorous treatment by including ATP along
with AP was used later to ensure complete removal of possible biotin sources.
In the biotinylation assay, AP-labeled proteins were exposed to excess biotin in
the presence of 1 tM BirA with or without the addition of ATP. Detection of the
biotinylated proteins following SDS-PAGE and western blot using streptavidin-HRP
revealed labeling only in the presence of ATP (Figure 1-1A).
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Full -Bio -ATP -BirA Ala
A B C
Figure 1-1: A: Streptavidin-HRP western blot ofp5OAP background biotinylation test. -bio lacks biotin, -
A TP lacks A TP, -BirA lacks biotin ligase, and Ala lacks the AP lysine B: In-gelfluorescence detection of
,fluorescein hydrazide is dependent on ketone biotin incorporation and presence of hydrazide. -KB lacks
ketone biotin and-FH lacks fluorescein hydrazide C: Coomassie stain offluorescein hydrazide gel. CFP
and BirA appear at 37 kD while p50-AP appears just below 50 kD. The observedfluorescence signal is not
due to uneven protein loading.
Equal protein loading was verified by Ponceau staining. Removal of pre-biotinylated
proteins and any biotin-AMP appeared complete as no background was detected in -ATP
lanes. The AP-tag was also accessible to BirA as biotin was incorporated when ATP was
available.
Once all AP-proteins and BirA were verified sufficiently pure free of biotin
contamination, ketone biotinylation and hydrazide conjugation were tested. AP-proteins
were incubated in the presence of BirA and racemic ketone biotin (KB) for three hours at
pH 8.2 in the presence of ATP to allow for labeling of the AP tag. The reaction was then
acidified to pH 6.2 to aid in hydrazide conjugation, and incubated with the fluorescein
hydrazide (FH) overnight. The resulting hydrazide adduct was reduced at 4 C for 1.5
hours prior to SDS-PAGE. Fluorescein was then detected in-gel on a STORM
fluorescence imager (Figure l-1B). Thereafter, Coomassie staining was employed to
reveal protein loading (Figure -1C). Only proteins in the presence of both KB and FH
were labeled.
Labeling was then repeated using a benzophenone-biotin hydrazide probe (BPBio,
Figure 1-2A). Ketone biotin labeling and hydrazide conjugation were conducted as
previously described, with BPBio hydrazide replacing fluorescein hydrazide. SDS-PAGE
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Figure 1-2: A: Structure of BPBio hydrazide probe B: Streptavidin-HRP blot ofp5O labeled with KB and
BPBio-Hydrazide. Full contains all components for labeling, negative lanes indicate the omitted
component. Ala represents the Lys to Ala mutant in the AP C: Streptavidin-HRP blot ofp5O labeled by
BPBio hydrazide and subjected to UV irradiation to trap dimmers. + Indicates a UV irradiated sample D:
Ponceau stain of BPBio-labeled p5O blot. Lover loading in UV lanes is likely due to crosslinking to the
container walls during irradiation
followed by Western blot and streptavidin-HRP development (Figure 1-2C) allowed for
visualization of the labeled proteins. An ATP-dependent labeling pattern was consistently
observed over many repeated labeling experiments. Exposure to the full reaction
conditions generated the strongest labeling, but significant background labeling was
observed in the absence of ketone biotin or BPBio hydrazide.
The high background labeling observed in BPBio labeling was initially attributed
to biotin contamination. AP-labeled proteins were subjected to additional streptavidin-
agarose columns, BirA was reacted a second time with synthetic AP and ATP, and BPBio
hydrazide was repurified by HPLC. Repetition of the labeling using the re-purified
reagents still generated this labeling pattern. However, reducing the protein concentration
1000-fold resulted in a clean labeling pattern showing the expected dependence on all
components of the labeling (Figure 1-2B).
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The ability to cross-link interacting proteins was also examined. BPBio labeled
samples were irradiated with long wave UV light on ice for 5-30 minutes prior to SDS-
PAGE and western blot. Evidence of cross-linking was then assayed by streptavidin-HRP
or silver staining. The BPBio hydrazide probe was unable to generate any significant
level of cross-linked proteins under these conditions. Earlier tests with ketone
biotinylation and fluorescein hydrazide labeling suggested that incorporation of ketone
biotin or hydrazide conjugation ruled out lack of incorporation of either KB or the
hydrazide probe. To test the cross-linking event itself, a second series of benzophenone
probes were synthesized.
Benzophenone probes for general labeling as well as site specific labeling were
prepared from commercially available compounds. Benzoylbenzoic acid was converted
to the NHS ester by carbodiimide activation of the carboxylic acid using EDC-
HCl. The benzophenone NHS ester (BP-NHS) was then reacted with either hydrazine to
generate the corresponding hydrazide (BP-Hyd) or with 4-aminobutryic acid to add a
flexible linker to the probe. The carboxylic acid was again activated with EDC-HCl in the
presence of NHS to form the benzophenone-linker-NHS ester (BP4AB-NHS). As earlier,
this was reacted with hydrazine to form the hydrazide (BP4AB-Hyd). All compounds
used for protein labeling were HPLC purified prior to use.
O 0 o
EDC-HCI hvdrazine 
OH DCM/MeOH DCM / MeOH 
O O
4-aminobutyric acid
THF / water
OO O O
H D M O H O 'H hvdrazine. H 0
cN-e1-OH DCMMeOH N,,v ON DCM /MeOH N-v.AL NNH 2
O O O O H
Scheme 1-1: Synthesis of benzophenone NHS esters and hydrazides
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Figure 1-3: A: Coomassie stain of BP-NHS ester labeling and crosslinking of CFPAP and p5OAP -
indicated the labeling component omitted and BPC is the benzophenone carboxylic acid B: Coomassie
stain of CFPAP cross-linking using BP-NHS or BP-linker-NHS (BP4AB) + indicates UV irradiated
samples.
Non-specific labeling and cross-linking was first examined in CFP and p50.
Concentrated stocks of both CFPAP and p5OAP proteins were treated with 5 equivalents
of either benzophenone NHS ester or benzophenone-linker NHS ester. Samples were UV
irradiated on ice and analyzed on SDS-PAGE with Coomassie staining. Exposure to the
NHS esters followed by UV irradiation generated a faint, higher weight band for both
CFPAP and p5OAP corresponding to the dimer (Figure 1-3A). Larger, higher order
complexes were also detected for CFPAP, and were more prominent when the BP-NHS
ester was employed. Some cross-linking was also noted when the parent benzophenone
carboxylic acid was used. Dialysis of the proteins before UV irradiation was used to
reduce this labeling without success. This background may be generated by hydrophobic
interactions between the probe and the protein, followed by multiple cycles of excitation
and radical recombination. As dimers were detected by photocrosslinking using these
benzophenone probes, the site-specific hydrazide variants were then examined.
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Figure 1-4: A: In-gelfluorescence image demonstrating competition offluorescein hydrazide by
increasing concentrations of benzophenone hydrazide on KB-labeled CFPAP. B: Coomassie stain of
CFPAP subjected to hydrazide labeling. Hydrazide probes used are indicated across the top and -BP
designates no hydrazide present.
Prior to cross-linking experiments with the BP-hydrazides, we determined
whether they reacted with ketone biotin. To examine this, CFPAP was labeled with
ketone biotin, and treated with 1 mM fluorescein hydrazide in the presence of increasing
concentrations of BP-hydrazide (Figure 1-4A). The intensity of fluorescein labeling
remained unchanged until the concentration of BP-hydrazide equaled that of fluorescein
hydrazide. A ten-fold excess of BP-hydrazide abolished fluorescein labeling. These data
suggest that the benzophenone hydrazide can label ketone biotin.
As CFPAP was available in higher concentration than p5OAP, it was used in
preliminary experiments for hydrazide conjugation and cross-linking tests. CFPAP was
subjected to ketone biotin labeling followed by hydrazide conjugation and reduction. All
three available hydrazide probes were examined in this assay. No cross-linking was
observed in the absence of UV irradiation, and only BP-hyd was capable of cross-linking
dimers. However, this cross-linking event was not dependant on ketone biotinylation. It
likely arises from the same phenomenon responsible for labeling in the presence of the
benzophenone carboxylic acid. As expected, UV irradiation in the absence of a
benzophenone source did not produce labeling.
14
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Discussion
The dimerization domain of NF-KB p50 was successfully expressed bearing both
an N-terminal His6 tag and C-terminal AP tag. While the expression of this protein from
the pRSETB plasmid was not particularly high, sufficient protein was collected for use in
assays. Further optimization of protein expression was achieved by transferring the gene
to pET2b(+), and is recommended for further work with p50 as it results in much higher
yield of protein.
The accessibility and functionality of the AP tag and the ketone biotin labeling
system were verified by a number of assays. Successful labeling of the AP tag with biotin
demonstrates both the accessibility of the AP tag as well as the ability of BirA to
recognize it within the fusion. Background signals due to pre-biotinylation in vivo as well
as trapped biotin-AMP ester copurified with BirA were readily removed by treatment
with streptavidin-agarose or synthetic AP, respectively.
Biotin can be replaced by ketone biotin for use with hydrazide probes with only
minor procedural modifications . As streptavidin cannot detect ketone biotinylation with
the amount of protein used in this assay, the ketone labeling was instead detected by
fluorescein hydrazide (FH). By allowing FH to react with the ketone, fluorescein-labeled
protein could be detected in a KB-dependent manner. Furthermore, the ketone-
biotinylated product was detected using the BP-biotin hydrazide probe, allowing for
detection by streptavidin-HRP. This labeling was dependent on the presence of all
labeling components, including ATP and the presence of the AP lysine. Thus the p50-AP
can be successfully labeled in the same manner as GFP and EGFR."M
In the absence of DNA, higher p50 concentration is required for dimerization.
Analytical centrifugation data estimates the dissociation constant in the low micromolar
range21. Thus, protein concentrations from 5-20 [xM in p50 were used for crosslinking
assays. At these concentrations, however, a higher background was noted in the detection
of the BP-Bio probe, particularly in -KB and -BP lanes. Given the high loading of
protein, it is possible that streptavidin will be able to weakly bind to ketone biotin and
give rise to the weaker background signal in -BP samples. Trace levels of biotin in the
BP-Bio probe may be responsible for the stronger background noted in the -KB lane. As
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multiple purifications were unable to eliminate this signal, it is possible that the free
biotin is due to slow degradation of BP-Bio. The use of EDTA to quench BirA activity
prior to BPBio addition was also unable to reduce this background. These background
signals, however, should not contribute to any photocrosslinking products as the previous
assays have shown that the hydrazide probe, and hence the benzophenone, are only
incorporated when all labeling components are present.
When BP-Bio labeled samples were irradiated at >320 nm at 0 °C for 2-30
minutes, no crosslinked products were observed. Neither silver staining (data not shown)
or streptavidin-HRP showed any bands corresponding to dimer or higher-order products.
As probe incorporation had already been established, it was necessary to establish the
functionality of the BPBio-hydrazide's crosslinking ability as well as its geometry. To
establish this, four new probes were synthesized bearing a benzophenone and either a
hydrazide, for site-specific linkage via ketone biotin, or an NHS ester, for linkage to
surface-exposed lysine residues.
Benzophenone-NHS probes successfully produced dimer bands upon UV irradiation. By
incubating p50 in the presence of 5 equivalents of BP-NHS or BP-Linker-NHS, a
sufficient amount of benzophenone probe was loaded onto the protein surface to allow
for photocrosslinking. This crosslinking was observed both in CFP controls as well as in
p50. The crystal structures of GFP variants 22' 23 and p5021 show a number of exposed
lysine residues near the dimer interface. It is likely that the labeling of these positions is
responsible for the formation of crosslinking products. This general surface labeling
confirmed the presence of dimers under the assay conditions.
Benzophenone hydrazide probes were unable to produce dimer bands. Lack of
hydrazide-ketone conjugation is unlikely to be a reason considering earlier labeling
experiments as well as evidence that BP-hydrazide can compete away fluorescein-
hydrazide labeling. The use of DNA bearing a p50 recognition site with or without added
myotrophin, a protein known to induce the dimerization of p50 in the presence of DNA'9 ,
failed to improve labeling.
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Figure 1-5: Crystal structures
of A GFP dimers23 and B p50
dimer interface. Side chains of
lysine residues 41, 45, 209, and
214 in GFP and 272, 275, and
312 in p50 near the dimer
interface are shown.
A
B
The dimer bands noted by BP-hydrazide have also been found in the free benzophenone
carboxylic acid, and are probably the product of hydrophobic interaction with the protein
surface and multiple crosslinkings during UV irradiation. While benzophenone normally
only forms one crosslink, the mechanism of photocrosslinking 24 does leave the possibility
of multiple excitations and linkages if the phenyl radical performs the recombination
instead of the carbonyl. Overall, none of the site-specific hydrazides could generate a
satisfactory dimer band.
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There are several possible reasons for the lack of site-specific crosslinking. One
such reason is poor probe-protein geometry. Successful crosslinking events have been
observed when using single, site-specific photophore labelings2 528, so the number of
photophores present is not likely an issue. However, their placement is quite critical. In
all previous reports, the photophores responsible for generating the protein-protein
linkages lie within close proximity to the interfaces between the proteins or between the
protein and the nucleic acid. Furthermore, these photophores have very little mobility in
their positions. Keeping the probe close to the interface and held in a rigid geometry to
further encourage the interaction of the photo-activated probe are necessary for efficient
crosslinkings. This is further demonstrated by the BP-NHS probes, which are
incorporated near the dimer interface, and with little mobility compared to AP.
In our current design, the AP places the photophore on the end of a flexible
peptide. As we lack data on the tertiary structure of the AP tag itself, it is possible that the
photophore is too distant from the dimer interface to efficiently crosslink the proteins.
The crystal structure does suggest that the AP tag may project over the p50 dimer
interface towards the interacting partner, but the tag also contains a poly-glycine region
that may give sufficient flexibility to the tag to move into a less productive orientation
away from the interface.
Another possibility is that the extent of ketone biotinylation and hydrazide
conjugation may be suboptimal. Its is not known at present if the current ketone
biotinylation conditions allow for complete labeling of all AP-tagged proteins in the
sample. If we assume hydrazide conjugation to be near complete, as the conditions used
are quite forcing including both long conjugations times and large excess of hydrazide to
ketone, the extent of ketone biotinylation will play a critical role in forming crosslinked
products. Because both fluorescence (Figure 1-lB) and streptavidin-HRP detection
(Figure 1-2B and C) are very sensitive, the observed signal may only represent a small
fraction of the total protein content. The extent of ketone biotinylation combined with
the considerations for the probe geometry relative to the dimer interface may reduce the
crosslinking efficiency to near zero.
Both probe geometry and labeling extent will need to be modified to ensure good
crosslinking efficiency. Movement of the AP tag from C- to N-terminal may bring the
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photophore closer to the dimer interface in the case of CFP, but will not work for p50.
The linker region between the AP and the protein could also be removed to bring the
photophore in closer to the interface. While much more difficult, it may also be
worthwhile to place the tag on an internal loop to force it to stay near the site of
interaction. Optimization of KB labeling will require close analysis of the labeling extent
followed by modifications of the time and concentrations of probe used to yield higher
labeling.
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Chapter 2: Design and synthesis of fluorescein phosphates for RNA selection
Introduction
Directed evolution methods have generated a variety of interesting and useful
nucleic acid-based tools. Included among these are RNA aptamers, which are RNAs that
adopt a secondary structure capable of selectively binding a target. Some of these take
advantage of pre-existing nucleic acid affinities such as aptamers selected for binding to
NF-KB p501, which mimic the structure of the DNA that p50 normally binds. Others are
capable of binding entirely non-biological entities such as small molecule fluorophores2 4 .
The modulation the fluorescence intensity of these dyes upon binding5 provides an
avenue towards RNA-based detection systems. Appending a fluorophore-binding
aptamer to an RNA would allow RNA tracking by fluorescence microscopy. This
parallels a technique using small peptide tags that bind fluorophores that has already been
demonstrated for protein tracking6. However, these methods lack any means of signal
amplification as they can only bind a single dye molecule. This is important in cases
where low copy numbers of the target are involved. Catalytic RNA species, known as
ribozymes, allow such amplification to occur by allowing a single tagged RNA to process
multiple dye molecules.
Like aptamers, a number of ribozymes with a variety of functions has been
isolated from random sequence libraries. Again, these may mimic the activities found in
natural ribozymes, such as phosphodiester transfer7 8, or perform more exotic roles
including the catalysis of Diels-Alder reactions9 and porphyrin metalationl0 .
Allosterically regulated ribozymes are capable of detecting divalent metal ions"l and
microRNAs'2. Ribozymes were particularly useful in the detection of miRNAs as they
provided a much higher signal intensity and turn-on in the presence of their target versus
conventional molecular beacons'2. Whether selecting for a ribozyme or an aptamer,
selection relies on the efficient separation of library members exhibiting the desired
activity from the rest of the pool.
The use of immobilized substrates in a selection can allow for the separation of
aptamer and ribozyme candidates from an RNA pool. Passing the library over a
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column bearing the immobilized substrate allows the RNA to bind to the target,
separating it from non-binding members that are washed away. Application of free
substrate in solution can then compete for the RNA on the stationary phase carry it into
solution for collection and amplification. Repeating iterative rounds of selection can yield
an aptamer to the substrate. Modifying the selection conditions from a competitive
elution to selection for probes capable of cleaving themselves from the solid phase allows
for ribozyme selections. However, the selection does not necessitate the use of an
immobilized substrate.
In some cases, gel electrophoresis may separate ribozymes from the RNA pool.
The selection of self-cleaving ribozymes is perhaps the simplest case. Cleavage results in
fragmentation of the parent RNA, and these smaller segments can be separated by size in
a gel, and thus isolated directly from the gell3. More subtle changes can be detected by
modification of the gel conditions. The presence of an organomercurial agent, such as
APM, within the gel selectively changes the mobility of thiol-containing compounds'4 . A
ribozyme capable of catalyzing the formation of uridine from thiouracil and activated
ribose was selected by isolating the RNA retarded by the incorporation of thiouracil in an
APM gel1'5. RNA bearing a activated ribose at their terminus were exposed to thiouracil.
Sequences capable of incorporating the thiouracil into their structure by forming
thiouridine from their activated ribose were separated from the pool by APM-PAGE.
Thus, these ribozymes were able to mimic the activity of uracil
phosphoribosyltransferase, While thiouracil was used for this selection, reduced mobility
in APM gels was originally found with thiophosphate monoesters T4
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Two sets of fluorescein-based probes were designed to use both immobilized and
in-gel selection techniques. The first uses the immobilized substrate - competitive elution
strategy to select for fluorescein phosphate aptamers and indirectly select for fluorescein
phosphatase candidates. A fluorescein thiophosphate was also synthesized for the direct
selection of a thiophosphatase using APM gels.
Results
A monomethyl fluorescein ether was synthesized for use in both phosphate
syntheses as well later probes. 5(6)-carboxyfluorescein is readily formed from the
condensation of resorcinol and trimellitic anhydride in methanesulfonic acid by adapting
the methods of Hirano et al'6 . Precipitation from cold water and copious washing
provided a nearly 1:1 mixture of regioisomers in near quantitative yield. Separation of
these isomers was effected using the methods of Rossi and Kao' 7. The 6-
carboxyfluorescein was then used for synthesis of the fluorescein methyl ether (6CFME)
following the methods of Takakusa et al'8. Improvement of yields in scale-ups of the 6-
carboxyfluorescin dimethyl ester by up to 30% was possible by increasing the reflux time
from overnight to 24 hours. Following methyl ether formation and methyl ester cleavage,
the resulting fluorescein methyl ether was used in the synthesis of fluorescein phosphates,
thiophosphates, and nucleoside-fluorescein conjugates. It was also possible to obtain the
desired fluorescein methyl ether by treatment of carboxyfluorescein in the presence of
excess base and methyl iodide followed by hydrolysis of the resulting methyl esters.
However, a large excess of base is required to force the fluorescein out of the lactonized
state to yield the monomethyl ether.
Both the fluorescein phosphate and fluorescein phosphate NHS ester were
synthesized according to Takakusa et a1'8 with some modifications (Scheme 2-1).
4,5-Dicyanoimidazole was found to be a good replacement for tetrazole as a
phosphoramidite activator during phosphate synthesis. NHS ester formation was
conducted as described in the literature, but deprotection of the phosphate by
hydrogenation proved intractable. Under these conditions, the NHS ester was often
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Scheme 2-1: Synthesis offluorescein methyl ether phosphate and thiophosphate NHS esters. a: X=O, b:
X=S
lost. However, the use of TMS-Br for deprotection1 9 followed by HPLC purification led
to the desired products.
Fluorescein diphosphate is a known substrate for alkaline phosphotase (CIP).
6CFME-phosphates should also be substrates, and thus an enzyme-based assay was used
to verify the integrity of the products. 6CFME-phosphate was monitored for fluorescence
in the presence and absence of CIP. A steady baseline was obtained in samples lacking
the phosphatase, while a strong fluorescence signal rapidly developed in the presence of
CIP (Figure 2-1). Satisfied with these results, a pair of solid phase resins for RNA
selection were made.
Both 6-carboxyfluorescein and 6-carboxyfluorscein phosphate resins were
produced from the NHS activated esters. 6-Carboxyfluorescein NHS ester was formed by
reaction with N-hydroxysuccimide (NHS) and DCC in DMF. The dicyclohexyl urea was
filtered off and the resulting NHS ester applied to 0.5 eq. Tentagel-HL-NH 2 resin. The
6CFME-phosphate resin was formed in a similar manner using the purified fluorescein
phosphate NHS ester. Both resins were washed thoroughly to remove unbound material.
Next, an RNA library was needed for selection of a phosphate-selective aptamer.
A region of 40 random nucleotides flanked by two different 15 nucleotide constant
regions was chosen for this task. KpnI and Csp45I sites were included in the constant
regions for cloning, and a T7 RNA polymerase promotor was used for in vitro
transcription. The DNA template was synthesized by MWG Biotech, and used with a T7
Flash polymerase kit to form the library. The resulting RNA was purified on a PAGE-
UREA gel, and the product band identified by UV-shadowing. The RNA was extracted
from the gel using a crush-soak method on the excised band. The integrity of the RNA
was confirmed by agarose gel as well as RT-PCR followed by cloning and sequencing.
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Prior to selection, the initial library was assayed for phosphatase activity. Several
commercial phosphate probes, including fluorescein diphosphate (FDP), DiFMUP, and
DDAO phosphate, as well as 6CFME-phosphate were included in the screen. The probes
were incubated at pH 8 in the presence of the RNA library and magnesium. In each case,
a CIP-treated sample was included as a positive control. The initial library showed no
phosphatase activity with any of the substrates even in the presence of magnesium.
Whether this is due to the lack of a catalytic member in the library or simply low copy
number could not be determined from this screening. However, the stability of the
phosphates to the assay conditions was found to be satisfactory.
500 -
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350 + CF + CIP + Mg
E
:C CF
mA 300
,,, 300 A S2RNA + CF + Mg
u 250 X S2RNA + CF + Mg
-S2RNA + CFU
200 -- S2RNA + CF
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Time (min)
Figure 2-2: Activity of RNA library towards fluorescein methyl ether phosphate (CF). No significant
fluorescence increase is noted with RNA from the second selection round (S2RNA). Only treatment with
alkaline phosphatase (CIP) produces afluorescence increase. These data are representative of both the
first round of selection and the initial library.
With both the library and immobilized substrates in hand, several rounds of
selection were attempted. Negative selection beads, bearing 6CFME, and positive
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selection beads, loaded with the 6CFME-phosphate, were blocked for 20 minutes using
3% BSA in RNA binding buffer. The beads were washed twice with binding buffer prior
to loading the RNA library. The library was then exposed to the negative selection
beads for 15 minutes to eliminate non-specific binders. The negative selection beads were
removed by centrifugation, and the supernatant was applied to positive selection beads.
The RNA was allowed 30 minutes at 37 °C for binding. Unbound RNA was removed by
washing the beads with 3% BSA and 0.1% Tween in binding buffer. Bound RNA was
eluted from the beads using 100 tM 6CFME-phosphate. The resulting RNA was
subjected to RT-PCR followed by cloning into pUC19 for sequencing.
The activity of the library was assayed after each of two round of selection.
Exposure of the library to RNA from either round of selection to 6CFME-phosphate in
the presence or absence of magnesium failed to show any catalytic activity (Figure 2-2).
Sequencing data from the two rounds did not show any common sequence emerging.
Further rounds of selection on a second library with these probes are being pursued.
A second selection system based upon fluorescein thiophosphate was also
created. The synthesis of thiophosphate was initially conducted using a diethyl phosphate
protection in place of dibenzyl. Chloro-diethylthiophosphate is commercially available,
and reacts with 6CFME in the presence of NaH to give the corresponding thiophosphate.
Attempts to deprotect this compound, however, were unsuccessful. Neither elevation of
temperature nor changes in solvent or deprotection reagent were capable of removing the
ethyl groups. A different approach was needed for the synthesis of the
thiophosphofluoresceins.
The earlier phosphoramidite method for generation of the fluorescein phosphates
was adapted to form the corresponding thiophosphates. Replacement of mCPBA with
elemental sulfur under inert atmosphere formed the dibenzyl-protected thiophosphate.
The rate of sulfurization is much slower than oxidation, but was accelerated by heating to
60 °C without damage to the compound. Purification by silica column met with mixed
results, and was replaced by purification by reverse-phase semi-preparative HPLC.
Formation of the NHS ester was accomplished by standard carbodiimide chemistry.
TMS-Br was again used to deprotect the thiophosphate. Cleavage of the benzyl
groups in either dry acetonitrile or dichloromethane at ambient temperature resulted in
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Figure 2-3: A: pH stability profile offluorescein thiophosphates monitored at 2 min intervals.
Fluorescence is normalized to 1 corresponding to the turn on of an equal concentration of FDP treated
with CIP. B: Stability of thiophosphate in the presence of alkaline phosphatase (CIP) at pH 8.
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cleavage of only one benzyl group. Reactions conducted at 55 °C in acetonitrile,
however, resulted in a mixture of products corresponding to the loss of either one or both
benzyl groups. These compounds were readily separated by reverse- phase HPLC to
provide the final product. Combined with N-acryloyl-p-aminophenylmercuric acetate
(APM), synthesized according the literature methods'4 , the thiophoshates are being used
for selection of a fluorescein thiophosphatase.
In preparation for use in-gel, two aspects of the thiophosphate were examined.
First, the stability of the thiophosphate at variable pH was assessed to address concerns of
degradation during DNA coupling or in the gel. Three pH values, used for either coupling
or are present in the gel, were examined. All three show a slow drift towards higher
fluorescence, but none of these values approaches the full fluorescence turn-on (Figure 2-
3A). Second, the stability of these compounds in the presence of alkaline phosphatase
was tested. No significant change was observed between phosphatase treated samples and
negative controls. The observed fluorescence was far below that of phosphatase-treated
FDP of equal concentration included as a positive control (Figure 2-3B).
Figure 2-4: APM-PAGE gel of TPF-labeled DNA. A TPF
conjugated to DNA, B CFME conjugated to DNA, C DNA only,
D TPF-conjugated DNA after NaOH treatement. DNA was 32p
-end labeledfor detection on a phosphor screen. Image
courtesy of Dr. D. Chinnapen, used with permission
A B C D
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Thiophosphofluorescein NHS ester (TPF) reduces the mobility of amine-labeled
DNA. An excess of a small DNA splint bearing a terminal amine was reacted with TPF
in carbonate buffer at pH 8. TPF-labeled DNA could be separated from unlabeled DNA
in a 16% polyacrylamide gel containing 80 ~1M APM (figure 2-4). The addition of the
non-thiophosphorylated fluorescein had identical mobility to the DNA alone. Thus,
APM-PAGE can successfully separate thiophorphorylated and non-thiophosphoyrlated
fluorescein-nucleic acid conjugates, and may be used for the selection of a
thiophosphatase ribozyme.
Discussion
Both fluorescein and phosphofluorescein required for aptamer selection were
successfully synthesized and immobilized on Tentagel resin. Furthermore, initial
selection rounds have been conducted using this resin pair. While these rounds did not
yield a consensus sequence or catalytic species, this is not entirely surprising. As this pair
of resins is better suited to aptamer selection, the chances of finding a catalytic species
within it without further selective pressure are rather low. However, both the use and
recovery of RNA from the beads demonstrates the potential of the system for selection of
a phosphate-specific aptamer. New libraries and modified selection procedures that
monitor for both binding and catalytic activity are being conducted with these resins.
Thiophoshate analogues of the resin-bound probes allows for the more direct
selection of a catalytic species. These compounds have demonstrated stability at
physiological pH as well as resistance to phosphatase treatment. While alkaline
phosphatase was unable to cleave the thiophosphate under the assay conditions, it is
likely that a ribozyme can be selected that is capable of this task. As alkaline phosphatase
cannot cleave this thiophosphate efficiently, it is possible that other phosphatases will
show poor activity towards this substrate, which is desirable when trying to limit
background hydrolysis in cell-based assays.
The thiophosphate NHS esters have been conjugated to amino-linked DNA splints
for use in ribozyme selection. The activated esters have been distributed within the lab
for further testing and ribozyme selection. Recent results from this work have shown that
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3 2 p end-labeled oligonucleotides bearing an primary amine linker are retarded on APM-
PAGE in a thiophosphate-dependant manner. Isolation and ligation of this splint DNA to
an RNA library will allow for the selection of thiophosphatase ribozymes. As both the
thiophosphate monoester and diester are available from this synthesis, it may also be
interesting to confirm that the conclusions of Igloi'4 concerning the complexation of
thiophosphates to mercury in-gel holds for a less sterically hindered aryl thiophosphate.
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Chapter 3: Design and synthesis of nucleoside-based fluorogenic probes for RNA
selection
Introduction
A healthy cell must produce a plethora of proteins at the right time as well as in
the right place. Improper timing or localization could lead to impairment of function or
cell death. Nature has constructed a complicated network of interactions to ensure the
proper correlation of protein expression with both the cell cycle and external stimuli.
Likewise, the cell has an array of methods to ensure that those proteins, once expressed,
reach their proper destination.
One method to properly target proteins to a specific location within a cell involves
the use of signaling sequences. These sequences are recognized by other components of
the cell for transport or for post-translational modification to assist in delivery. Examples
of such signals include nuclear localization sequences" 2 and the CAAX motif found in
p21 Ras that signals for farnesylation necessary for membrane localization3 -5. However,
such tags are not the only method available for the control of protein localization.
Localization of mRNA transcripts also provides spatial control of protein
expression. Transportation of mRNA to specific sites within the cell allows for
expression of the encoded protein where it is needed. Localization of mRNA is a
significant phenomenon during development. Among the best-studied examples of these
are bicoid and nanos transcripts in Drosophila oocytes. These transcripts encode proteins
responsible for differentiation of posterior and anterior body plans, and are localized to
opposite poles of the oocyte6 ' 7. Many localized transcripts have also been found
important in the development in Xenopus oocytes7. Improper localization of these
transcripts would lead to disruption of normal development. The importance of RNA
localization is, however, not limited to that observed in development.
Localization of mRNA's within neurons has been observed in both dendrites and
axons. Transcripts localized to the axon include, but are not limited to, those of
vasopressin and oxytocin in mammals and neurofilament proteins in squid giant axons8.
Localization of myelin transcripts to distal portions of oligodendrocytes has been
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implicated in the delivery of myelin proteins9 . A number of RNAs appear at dendritic
sites along with synapse associated polyribosome complexes for their translation6 ' 10
Detection of these transcripts, however, has many limitations.
Perhaps the most sensitive means of RNA detection is PCR. As PCR confers
amplification of the transcripts, detection of targets present in low copy number is
possible. Amplification of dendritic or axonal transcripts, however, is not simple. RNA
from these cellular processes must be collected without contamination from the soma or
from neighboring neurons or glia. Collection of the RNA also disrupts the cellular
structure, causing loss of spatial and temporal information. While very sensitive, PCR
cannot provide sufficient spatial or temporal information. In situ hybridization, however,
can provide a better image of RNA localization.
In situ hybridization is a method of saturation binding followed by excess probe
removal. A set of cells is first fixed, then permeablized to allow probe entry. An excess of
labeling reagent, complimentary to the RNA to be studied, is added and the excess
washed away. The localization of the probe can then be studied using microscopy as in
the case of fluorescence in situ hybridization. While this provides a more precise location
of RNA transcripts, it requires fixation of the cell and thus loss of temporal information
in RNA trafficking. An in vivo imaging agent would allow for the preservation of both
spatial and temporal data.
Molecular beacons allow imaging of RNA localization in vivo. These probes
consist of nucleic acid sequences with a fluorophore and a quencher attached at opposite
ends. When isolated, the beacons have a stem-loop conformation that places quencher
and fluorophore in close proximity. When the probe hybridizes with its target RNA
sequence, the quencher and fluorophore are separated, resulting in a fluorescent signal.
While these probes are quite versatile, they suffer from several drawbacks.
Background fluorescence due to nuclease activity, difficulty in probe delivery,
and lack of signal amplification are common problems experienced when using
molecular beacons. DNA and RNA based molecular beacons are degraded by their
respective nucleases, resulting in false positives. Solutions to these problems include the
use of 2'0 methyl ribonucleotides to confer nuclease resistance" or molecular beacon
FRET pairsl2. These probes, however, still require microinjection, making their use on
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large cell populations difficult. Molecular beacon delivery by fusion to TAT peptide
appears to be a feasible solution to these delivery issues1 3. While these efforts have made
the use of molecular beacons more feasible, they still may not be able to detect mRNAs
present in very low numbers as they lack any form of signal amplification. A new in vivo
imaging system would be able to confer the spatial and temporal resolution of molecular
probes with sensitivity enhancement by signal amplification. Ribozymes provide an
attractive route to such a target.
Ribozymes are RNA species with catalytic activity. While they vary in size and
secondary structure, they typically catalyze the cleavage and formation of phosphodiester
bonds. Ribozymes are not limited to these reactions, as has been demonstrated by
ribozymes that catalyze Diels-Alder reactions14. Another example selected for by in vitro
evolution methods includes ribozymes capable of nucleotide synthesis'5. Appending a
ribozyme to an RNA would allow for a genetically encoded RNA tracking device. Its
catalytic activity could provide signal amplification detectable by fluorescence
microscopy when provided with a matching fluorogenic substrate. With the proper
selection criteria, the selection of such a ribozyme is possible.
Selection of a ribozyme requires a means of separating catalytic targets from
inactive members of a library. Immobilization of the substrate on a solid phase support
allows for the exclusion of non-binding RNA's in the library. By anchoring the solid
phase to one end of the substrate and the ribozyme binding position to the other, catalytic
RNA that cleaves the probe in half can be collected after application of selection
conditions, such as the addition of magnesium, by rinsing the resin and collecting the
filtrate. Amplification of this pool by PCR provides a new library for further rounds of
selection. The use of this strategy, however, requires the synthesis of an appropriate
immobilized substrate.
A nucleoside-fluorescein conjugate was chosen as the substrate for the ribozyme.
The dye bears a fluorophore attached to a nucleoside in a manner similar to RNA. Upon
recognition, the ribozyme, which will be fused to a target RNA, will catalyze the
formation of a 2'0-3'0 cyclic phosphate with release of the fluorophore (Figure 3-1).
Thus, the tracked RNA will generate a fluorescent signal in the presence of the dye
substrate that can be monitored by fluorescence microscopy.
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Figure 3-1: Mechanism of ribozyme-catalyzed release offluorophore and generation offluorescent signal
Results
Selective protection of the 5' and 3' hydroxyl groups was achieved by use of
TIPDS-C12 6 . Treatment with 1.1 eq of the disilyl reagent in pyridine gave the protected
nucleosides in nearly quantitative yield. Masking of the adenosine N6 amino group was
also necessary. Pre-treatment with TMS-C1 to temporarily block the 2' hydroxyl followed
by the addition of Bz-Cl and subsequent NH40H treatment provided the mono-
benzoylated adduct' 7. The product was also obtained by treatment with excess Bz-Cl to
give the 2'0, N6, N6-tribenzoylated intermediate. Sodium methoxide in ethanol on ice for
15-30 minutes then provided the N6-benzoylated product16 . From this product, protection
of the 2' position and exposure of the 3' for fluorescein coupling could proceed.
Two variants on the acid-labile 2'0 protection with 5'0 silyl protection were
synthesized. Neat ACE orthoester in the presence of PPTS at elevated temperatures under
vacuum followed by TEA / HF treatment generated the 2'0-ACE protected compound
with free 3'0 and 5'0 sites in modest yield'8. The use of ACE for 2' protection was later
replaced by THP as it was more readily available, could be installed in quantitative yield
in the presence of catalytic TsOH, and was stable to TEA / HF cleavage conditions to
provide the 2'0 protected adduct in higher yield. For both compounds, we relied on the
preference of the TBDMS group for the primary hydroxyl to give the 5'0-TBDMS
adducts which were then ready for use in phosphoramidite chemistry.
Generation of the fluorescein - nucleoside phosphate junction required two
stages. First, the 3' hydroxyl is converted to the phosphoramidite by reaction with
(iPr 2N) 2POMe in the presence of 4,5-dicyanoimidazole (DCI) as an activator. Anhydrous
conditions under inert atmosphere are necessary at this stage to prevent oxidation or the
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formation of the phosphite. The nucleoside phosphoramidite was separated from excess
phosphordiamidite by silica chromatography followed by drying under vacuum. 6-
Carboxyfluorescein methyl ether (6CFME) and 4-5 dicyanoimidazole (DCI) were then
added and the atmosphere replaced with argon. Coupling proceeded in dry acetonitrile at
ambient temperature, generally reaching completion within 30 minutes. Complete
consumption of the phosphoramidite and the presence of the phosphite intermediate were
observed by ESI-MS in positive ion mode. Oxidation of this intermediate to the
phosphate proceeded smoothly upon addition of excess mCPBA.
Purification of the nucleoside-fluorescein phosphate triester proved problematic.
Pure samples of the ACE and THP protected compounds could not be isolated from silica
columns under a multitude of conditions. Before the availability of an easily accessed
ESI-MS, the reactions were thought to have failed entirely. Commercial 2'0-ACE, 5'0-
silyl protected 3'0 adenosine phosphoramidite was purchased from Dharmacon to
troubleshoot the reactions without success until LC/MS was available for analysis.
Purification of the commercial adenosine probe, as well as the THP-protected compound,
was then completed on a reverse phase column.
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Scheme 3-1: Synthesis of acid-labile 2 'O protected 3 'O-fluorescein phosphates. A: R=ACE, B: R=THP
Two additional adenosine-based probes were synthesized from intermediates in
the acid-labile 2'0 strategy. The first of these uses the tribenzoylated intermediate
isolated during the benzoyl protection of the adenosine N6 position. The 3'0, 5'0- silyl
deprotection was cleaved in the presence of TEA / HF, and the 5' O-TBDMS protection
installed as previously described. Application of the same two-stage phosphate formation
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yielded the adenosine-fluorescein conjugate. The second derivative replaces the 2'0
protection step with the phosphate linkage to the fluorescein to provide a 2'0 fluorescein
phosphate with 3'0-5'0-TIPDS protection.
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Scheme 3-2: 2 'O-fluorescein phosphate synthetic strategy and observed side products
In preparation for loading onto the silyl resin, the 5'0 protecting groups were
removed. The standard TIPDS removal conditions using TEA / HF were unsuitable for
the 2'0 phosphate as the basic conditions caused the free 3' hydroxyl to attack the
phosphate and form the cyclic AMP ester with loss of fluorescein. Removal of TEA from
the system to provide more acidic conditions still failed to prevent cyclization, and only a
partial fluoridolysis product could be isolated. Thus, the 2'0 phosphate strategy was
abandoned. Removal of the 5'0 TBDMS from the tribenzoyl derivative proceeded
smoothly in the presence of dilute HF. Fluoridolysis of the silyl groups in both ACE and
THP derivatives gave very low yield over a variety of conditions as indicated by LC/MS
and from purified reactions.
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Scheme 3-3: Synthesis of tribenzoyl adenosinefluorescein phosphate before solid phase loading
Before attempting resin loading, the deprotection steps to follow while on solid
phase were tested in solution. The first of these is removal of the phosphate methoxy
protection to yield the phosphate diester. Treatment with a 1 M solution of disodium-2-
carbamoyl-2-cyanoethylene- 1,1-dithiolate trihydrate (S2Na2) in DMF for 1 hour gave
complete conversion to the phosphate diester, which could be purified by reverse phase
HPLC. Several attempts to remove the acetyl groups of ACE or the 2'0-benzoyl
protection on the tribenzoyl-adenosine with primary amines suffered from the same
cyclization event observed in the 2'0-fluorescein phosphate method. Efforts were then
focused on the 2'0-THP strategy to make the final probe suitable for solid phase use.
The 5'0-TBDMS and 3'0-THP deprotections were closely examined by a
combination of ESI-MS and LC/MS. TBDMS cleavage was tested under a variety of
fluorine sources including varied concentrations of HF, TEA / HF, pyridine / HF, and
TBAF. Removal of THP was attempted under acidic conditions as well as under neutral
conditions with Lewis acid catalysts'9' 20. All buffered fluorine sources were capable of
cleaving the TBDMS group without displacement of the THP. Unfortunately, it was
discovered that fluoridolysis of the phosphate triester to form a fluorophosphate with
release of fluorescein was far more facile than removal of TBDMS. Unbuffered HF was
capable of removing the TBDMS group with a significant loss of THP as well. Non-
specific cleavage of both TBDMS and THP were noted in most acid-promoted cleavages
for THP despite some cases of selectivity found in the literature. The use of Lewis acid-
promoted cleavage under neutral conditions, also known to be selective for THP over
38
TBDMS, was incompatible with the phosphate as both the triester and diester were
rapidly converted to cyclic AMP esters with loss of fluorescein.
An orthogonal approach to the fluorescein-nucleoside probe was necessary as the
current strategy was incompatible with the sensitive -hydroxyl aryl phosphate. A 5'0-
dimethoxytrityl (DMTr) and 2'0-p-methoxybenzyl (PMB) system was chosen to replace
the earlier system. Direct incorporation of PMB to the 2'0 position of 5'0-3'0 TIPDS
protected adenosine or uridine was found to be difficult due steric crowding at the site.
Benzylation of the nucleobase was more prominent under the conditions examined. The
use of a 2'0-3'O-(dibutylstannylene)-uridine 2 ' was chosen as an alternative route.
Reaction of the tin complex with PMB-Cl at 110 °C in dry DMF yielded a mixture of 2'0
and 3'0-PMB uridines. The 5'OH was then selectively protected using DMTr-C in
pyridine2 1 .
Conjugation of the fluorescein-uridine conjugate and 5' deprotection was
examined next. The earlier strategy of phosphoramidite formation followed by
fluorescein addition and oxidation yielded the desired product without the need for any
further protection of the uridine. Removal of the DMTr group from the crude mixture
was observed using 1.5% TsOH in 10% (v/v) MeOH / DCM at ambient temperature, and
the product verified by ESI/MS/MS.
Discussion
Several routes and model compounds have resulted from the efforts to generate a
solid-phase selection probe. These models allowed for insight into the reactivity of the
aryl phosphate triester and considerations that must be made in attempting to immobilize
this target. The acid-catalyzed deprotection and nucleophilic deprotection models
contributed to this knowledge in their own ways.
From the nucleophilic deprotection models, the stability of the aryl phosphate
triester was assessed during 5'OH deprotection. As these model compounds used silyl
protection in both cases, fluoridolysis was chosen for their removal. The TBDMS group
in the 2'0-benzoyl protected model was readily removed in dilute hydrofluoric acid in
acetonitrile without formation of the cyclic phosphate or loss of the 2'0 protection. 5'0-
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3'0-TIPDS protection, however, was not successfully removed under these conditions.
Even without a basic buffering agent, the phosphate triester was attacked by the exposed
13'OH to yield the cyclic phosphate with loss of fluorescein. Likewise, the phosphate
triester could not be exposed to the 2'OH during hydrolysis of the benzoyl ester without
cyclization occurring. Thus from these models, the necessity of a non-nucleophilic
cleavage of the neighboring protecting group will be necessary for successful probe
synthesis.
As nucleophilic cleavages of the protecting groups cannot yield a stable product,
acid-catalyzed deprotection was examined, and made to mimic the current RNA synthesis
procedures. Both the ACE protecting group (Dharmacon) and the tetrahydropyranyl
(THP) were examined as 2'0 protecting agents. In both cases, 5'0 silyl protection was
used. Both compounds could be incorporated at the 2' position under mild acidic
conditions. Removal of the TIPDS protection followed by selective protection of the
primary hydroxyl allowed for a 3'0 fluorescein phosphate to be synthesized. Before
these probes could be loaded onto solid phase, the 5'0 silyl protection needed to be
removed. The use of TEA / HF as in commercial synthesis was found to be unsatisfactory
with this system. Unlike the alkyl phosphate triesters, the fluorescein phosphate triester
was readily cleaved by the basic fluoride ion to release fluorescein. Several attempts to
decrease the nucleophilicity of the fluoride ion by increasing the ratio of HF to buffering
agents such as triethylamine and pyridine failed to improve the situation. Only in the
presence of dilute HF was 5'0 deprotection successful. However, this also yielded loss of
the ACE and THP groups as indicated by LC/MS. It should be noted that the phosphate
diester, lacking the methyl protection, is stable to TEA /HF treatment at ambient
temperature. While this series of probes cannot provide the selectivity for 5' versus 2'
deprotection needed on the silyl resin, it does offer a viable route to the solution-phase
synthesis of the free dye that will be needed for later experiments. Solid-phase probes,
however, will require an alternative route.
Based on the knowledge gained from the earlier synthetic routes, the 4-
methoxybenzyl (PMB) group was chosen for the protection of the 2'OH. The PMB group
is stable to acidic conditions allowing for the use of TsOH treatment for 5'OH
deprotection. Unlike the benzoyl and acid-labile protecting groups, PMB can be cleaved
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oxidatively in the presence of DDQ in water / dichloromethane. PMB is also cleaved at a
much higher rate than an unmodified benzyl group, allowing for more rapid deprotection
without damage to the resin itself. Furthermore, DDQ has been used in the presence
phosphates for deprotection2 2 and should leave the phosphate diester untouched.
Use of the TIPDS-protected nucleosides proved difficult for 2'0 PMB protection.
Several attempts under a variety of conditions including variations in the base used,
temperature, solvent, concentration, and the presence of catalysts such as TBAI failed to
produce the 2'0 protected product. While there are a few examples of this protection in
the literature, the replication of these strategies was unsuccessful with PMB-Cl. To
circumvent this problem, 2'0-3 'O-(dibutylstannylene)-uridine was synthesized2 1.
Treatment of this complex at 110 °C in dry DMF successfully generated a mixture of 2'0
and 3'0 PMB uridines in modest yield. These compounds could then be 5'0 protected
with either TBDMS or DMTr to give either an open 2'0 or 3'0 position for fluorescein
phosphate formation.
Coupling of the fluorescein to these analogs to proceeded in a similar manner as
the four model compounds presented earlier. It may also be possible to purify these
compounds in a manner similar to that of the 2'O-benzoyl model, provided the compound
proves to be stable on silica. However, reverse-phase purification is recommended to
ensure complete removal of excess fluorescein. Detritylation of the 5'OH is possible with
TsOH. The 5'OH deprotected compound is then ready for solid phase loading.
To finish the probe, a few modifications must be conducted on solid phase
(Scheme 3-4). Once the probe is bound to the solid phase, the carboxylic acid of
fluorescein is activated using a carbodiimide such as EDC-HCl in the presence of N-
hydroxysuccinimide to form the activated ester. Excess EDC must be washed away
afterwards to prevent it from activated the phosphate groups of the amine-bearing DNA
oligonucleotide that is added next. Similarly, the fluorescein phosphate must not be
deprotected until the DNA has been coupled to the probe. Treatment of this resin with
S2Na2 (Dharmacon) in DMF will then yield the deprotected phosphate. The final step in
the probe synthesis is the treatment of the resin with aq. DDQ in dichloromethane. This
removes the PMB group and leaves the fully deprotected probe bound to the resin.
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The resin can then be treated with the RNA library bearing a constant region
complimentary to the DNA oligo located on the resin. Once the library is bound to the
probe on the resin, the conditions for cleavage can be made permissive by the addition of
magnesium to the buffer. Any ribozyme capable of cleaving the cleaving the phosphate
bond at that point will sever itself from the resin for recover and amplification by RT-
PCR. Repeated iterative rounds of selection should then yield a species with the desired
catalytic activity.
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Scheme 3-4: General loading procedure and deprotection for solid phase selection probe
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Materials and Methods
General
All chemicals were purchased from Sigma-Aldrich, Alfa Aeser, TCI America,
Dharmacon, or Lancaster Synthesis and used without further purification.
Tetrahydrofuran was distilled over Na / benzophenone prior to use. Acetonitrile was
distilled over CaH2 for anhydrous work. Methanol, ethyl acetate, hexanes, absolute
ethanol, pyridine, and toluene were used as received. Dichloromethane was used as
received for general use and distilled over CaH2 for anhydrous applications. Dry dioxane
and DMF were used as received and stored under argon in the presence of 4 A molecular
sieves. Analytical thin layer chromatography (TLC) was conducted using 0.25 mm silica
gel 60 F254 plates. Flash chromatography was conducted using silica gel (ICN SiliTech
32-63D).
Chapter 1:
p-Benzoyl-benzoic acid N-hydroxysuccinimidyl ester (BP-NHS)
O 0
OH N
p-benzoylbenzoic acid was dissolved in 9:1 DCM / MeOH followed by 1.1 eq N-
hydroxysuccinimide and 1.1 eq EDC-HCl. The solution was stirred at RT and monitored
by TLC (2% MeOH in DCM). At completion, the reaction was diluted with DCM,
washed with brine, and dried over Na2SO4. The solvent was removed in vacuo and the
residue purified over silica using 0% to 5% MeOH in DCM to yield a white solid. Rf =
0.36 'H-NMR (400 MHz, CDC13): 8.28 (2H, m), 7.90 (2H, m), 7.81 (2H, m), 7.63 (1H,
m), 7.49 (2H, m), 2.94 (4H, s)
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BP-Hydrazide
N ' NNH
0O O~~0
BP-NHS was dissolved in 10 mL DCM and slowly added to a solution of 20 eq.
hydrazine in 5:1 DCM / EtOH over 7 minutes. The reaction was stirred at RT for two
hours until ESI-MS showed complete consumption of the starting material and only
product. The solution was concentrated in vacuo and redissolved into EtOAc. The
organic later was washed twice with brine and dried over Na2SO4. Removal of the
solvent yielded a white solid. 1H-NMR (400 MHz, DMSO-D 6) 8 10.00 (1H, s), 7.97 (2H,
d, J = 8 Hz), 7.80-7.68 (5H, m), 7.58 (2H, t, J = 8 Hz), 4.66 (2H, bs) 3C-NMR (100
MHz, DMSO-D 6) b 195.4, 164.9, 139.0, 136.7, 136.6, 133.0, 129.7, 129.5, 128.7, 127.2
ESI-MS [M+H]+ calc 241.1 found 241.1
BP-4AB
a 2 H
1.2 eq. 4-aminobutyric acid was dissolved in water and added to a solution of BP-NHS in
2 volumes THF. A cloudy solution resulted that slowly became clear as the reaction
progressed. The reaction was monitored by TLC (5% MeOH in DCM with 1% AcOH)
and the solvent removed in vacuo upon completion and the residue dissolved in DCM.
The organic layer was washed twice with brine and dried over Na2SO4. The residue was
purified over silica using 0% to 5% MeOH in DCM to obtain a white solid. Rf = 0.24
1H-NMR (500 MHz, CDC13 / MeOD): 7.89-7.87 (2H, m), 7.80-7.74 (4H, m), 7.60-7.57
(1H, m), 7.58-7.45 (2H, m), 3.47 (2H, t, J= 7 Hz), 2.41 (2H, t, J= 7 Hz), 1.93 (2H, pent,
J= 7 Hz) 13C-NMR (125 MHz, CDC13 / MeOD): 196.7, 176.5, 167.4, 140.0, 137.8,
45
137.0, 133.1, 130.2, 130.1, 129.9, 129.8, 128.6, 127.2, 39.8, 31.8, 24.3 ESI-MS [M-H]-
calc. 310.11 found 310.11
BP-4AB-NHS
0 0
o o 0CAH ° 'a i3
BP-4AB was dissolved in 5:1 DCM / MeOH followed by 1.4 eq NHS and 1.4 eq EDC-
HCI. The solution was stirred at RT and monitored by TLC (4% MeOH / DCM) with the
product appearing at Rf = 0.35. Upon completion, the reaction was diluted with DCM,
washed with brine, and dried over Na2SO4. The residue was purified over silica using 0%
to 5% MeOH in DCM. Material used for protein labeling was purified a second time by
reverse phase semi-preparative HPLC. Using a 300 A column with a gradient of 25% to
85% acetonitrile in water with 0.1% TFA at 4.7 mL / min, the product eluted at 11
minutes as monitored by UV absorbance at 254 nm. The product was lyophilized to yield
a white powder. H-NMR (400 MHz, CDC13) 8 7.90-7.78 (6H, m), 7.62 (1H, t, J = 8 Hz),
7.50 (2H, t, J=8 Hz), 6.86 (1H, t, J=6 Hz), 3.60 (2H, q, J=6 Hz), 2.85 (4H, s), 2.75 (2H, t,
J= 7 Hz), 2.17-2.12 (2H, m) 13C-NMR (100 MHz, CDC13): 196.3, 169.5, 168.7, 167.2,
140.2, 137.8, 137.2, 133.1, 130.3, 128.7, 127.2, 39.1, 28.7, 25.8, 24.5 ESI+MS [M+H]+
calc. 409.14 found 409.14
BP-4AB-Hydrazide
o 0
H 0 H 0c N .OH -- N~NLNH2
0 0 H
BP-4AB was dissolved in 4:1 DCM / MeOH followed by the addition of 10 eq.
hydrazine. 1.4 eq. EDC-HCl was then added and the solution stirred at RT for 1 hour.
TLC (4% MeOH in DCM) showed complete conversion to product at Rf = 0.21. The
reaction was diluted with DCM, washed with brine, and dried over Na2SO4. Purification
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was done first by silica column using a gradient of 0% to 5% MeOH in DCM and later by
semi-preparative HPLC using the same conditions as for BP-4AB-NHS with an elution
time of 7 minutes. 'H-NMR (300 MHz, CDC13 / MeOD) 8 9.6 (1H, s), 8.5 (1H, s), 7.92
(2H, t, J = 8 Hz), 7.77 (4H, m), 7.56 (1H, t, J = 7 Hz), 7,47 (2H, t, J = 7 Hz), 2.85 (2H,
m), 1.83 (2H, m) ESI-MS [M+H] + calc. 326.2 found 326.2
p5OAP in pRSETB
The acceptor peptide (AP) was appended to the C-terminus of truncated murine p50 by
PCR with the forward primer 5-GATAAGGATCCGGCCCCATACCTTGAAATATT,
which introduced a 5' BamHI site, and the reverse primer 5'-
TCATGAATTCTTACTCGTGCCACTCGATCTTCTGGGCCTCGAAGATGTCGTTCAGGCCG
CCGCCGGAGGACTCCTTGTACAGCTCCTTCTGGCGTTTCCTTTG, containing the AP
sequence, stop codon, and 3' EcoRI site for cloning. Taq polymerase was used the
amplify the p50 gene using a PCR cycle consisting of a 2 min 95 °C initial denaturation,
24 cycles of 30 sec 95 °C, 30 sec 50-62 °C annealing using 0.5 °C increments / cycle, 1.5
min 72 °C elongation, and a 3 min 72 °C final elongation step. A 1% agarose gel was
used to purify the resulting transcript. A band at -1 kb was excised and the DNA
extracted using a Qiagen gel extraction kit according to manufacturers instructions.
pRSETB was prepared for cloning by double digest using EcoRI and BamHI at 37 °C for
2.5 hours in NEB EcoRI buffer in the presence of BSA. The plasmid was purified on a
0.8 % agarose gel and purified by gel extraction. The plasmid was treated with alkaline
phosphotase in NEB Buffer 3 for 1 hour at 37 °C. DNA was purified using a Qiagen PCR
cleanup kit and the product eluted with 30 tL EB buffer. The insert was ligated to the
plasmid using T4 DNA ligase at RT for 3 hours in T4 ligase buffer. The resulting
plasmids were transformed into DH5c cells by 45 sec 42 C heat shock followed by
immediate rescue in 500 tL SOB at 37 °C with shaking for 40 min. Bacteria were plated
on LB-Amp plates and grown overnight at 37 °C. Colonies were selected and grown in 5
mL LB-Amp cultures at 37 °C overnight. Plamsids were isolated by Qiagen miniprep kit
according to manufacturer's instructions. Plasmids were confirmed by BamHI / EcoRI
digest and DNA sequencing.
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p5OAla in pRSETB
The AP lysine was mutated to alanine using site directed mutagenesis. Pfu Turbo
polymerase (Invitrogen) was used with the primers 5' -
CGACATCTTCGAGGCCCAGGCGATCGAGTGGCACG and 5' -
CGTGCCACTCGATCGCCTGGGCCTCGAAGATGTCG with the PCR cycle 30 sec 95 °C
initial denaturation, 18 cycles 30 sec 95 °C denaturation, 1 min 55 °C annealing, 15 min
68 °C elongation, followed by a 8 min 68 °C final elongation step. The resulting plasmid
was digested for 2 hours at 37 °C with DpnI to degrade the wild type plasmid. Plasmids
were transformed into XL1 Blue by heat shock, rescued in SOB at 37 °C for 30 min, and
plated on LB-Amp plates at 37 °C overnight. Single colonies were miniprepped from 5
mL LB-Amp cultures according to manufacturer's instructions, and confirmed by
analytical digestion and sequencing.
Transfer of p50OAP and p50Ala from pRSETB to pET21b(+)
Both p50OAP and p50OAla in pRSETB were excised by EcoRI / BamHI double digest
followed by 0.5% agarose gel purification and gel extraction. pET21b(+) was digested
with BamHI and EcoRI and also subjected to agarose gel purification followed by
alkaline phosphotase treatment as described earlier. The inserts were ligated using a 2
hour T4 ligase reaction at ambient temperature. Plasmids were transformed into DH5a by
heat shock, rescued in SOB at 37 °C for 40 min, and plated on LB-Amp plates overnight
a 37 °C. Colonies were selected and mini-prepped from 5 mL LB-Amp cultures grown
overnight at 37 C. Plasmids were confirmed by analytical digest and sequencing. As
pET21b(+) encodes a C-terminal His6-tag for purification, the stop codon following the
AP tag was removed by site-directed mutagenesis using the primers 5'-
GATCGAGTGGCACGAGAAGAATTCGAGCTCCG AND 5' -
CGGAGCTCGAATTCTTCTCGTGCCACTCGATC to leave a small linker between the AP
and the His-tag. The previous mutagenesis PCR sequence was modified to increment the
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annealing temperature by 0.5 °C after each round and DH5a was used for
transformations and plasmid isolation. Sequences were confirmed for each plasmid.
Expression of BirA
BirA in pBTac2 was transformed into E. coli strain JM109 by 45 second, 42 °C heat
shock followed by immediate rescue in 0.5 mL SOB at 37 C with shaking for 40
minutes. 0.1 mL was then plated on LB-Ampicillin plates and incubated at 37 °C
overnight. Single colonies were chosen and grown in Luria Bertani broth supplemented
with 100 tg/mL ampicillin (LB-Amp) at 37 °C to saturation. This culture was then
diluted 1:1000 into LB broth supplemented with ampicillin (100 Etg/mL). BirA was
grown to an OD600 = 0.9 at 37 °C with shaking (220 rpm) and induced with IPTG to a
final concentration of 0.4 mM. Induced BirA cultures were grown an additional 4 hours
at 30 C with shaking. Cells were collected by centrifugation followed by lysis by
sonication at 4 °C (four 30-second pulses at half-maximal power with 1 minute between
each pulse) in lysis buffer (50 mM Tris pH 7.8, 300 mM NaC1l) containing 5 mM
phenylmethyl-sulfonyl fluoride (PMSF) and protease inhibitor cocktail (Calbiochem).
The His6-tagged enzyme was purified from the lysate using Ni-NTA agarose (Qiagen).
Fractions containing enzyme were combined and dialyzed against PBS pH 7.4. To
remove biotin-AMP ester in the active site, the protein was incubated at 30 °C in the
presence of 1 mM synthetic AP and 4 mM ATP for 1 hour. The protein was then
repurified by Ni-NTA column and dialyzed against PBS pH 7.4.
Expression of CFP and p50 proteins
CFPAP, CFPAla, p50AP, and p50Ala (all in pRSETB) were expressed in E. coli strain
BL21(DE3). Bacteria were transformed by 45 second heat shock at 42 °C followed by
rescue in 0.5 mL SOB for 30 minutes and plated on LB-Amp plates overnight at 37 °C.
Bacteria were grown at 37 °C to an OD600 = 0.2 and induced with IPTG to a final
concentration of 0.4 mM followed by incubation overnight at 25 °C with shaking. Cells
were collected by centrifugation followed by lysis by sonication at 4 °C (four 30-second
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pulses at half-maximal power with 1 minute between each pulse) in lysis buffer (50 mM
Tris pH 7.8, 300 mM NaCl) containing 5 mM phenylmethyl-sulfonyl fluoride (PMSF)
and protease inhibitor cocktail (Calbiochem). The His6 -tagged enzyme was purified from
the lysate using Ni-NTA agarose (Qiagen). Fractions containing enzyme were combined
and dialyzed against PBS pH 7.4. AP-tagged proteins were then filtered over a column of
streptavidin agarose four times to remove pre-biotinylated proteins.
Biotinylation assays
1 tM AP-tagged protein was treated with 1 tM BirA in the presence of 4 mM ATP and 1
mM biotin in 50 mM bicine buffer pH 8.2 supplemented with 5 mM Mg(OAc) 2 for 1
hour at 30 C. The reaction was then diluted with protein loading buffer and heated to
100 C for 15 minutes. Samples were subjected to 12% SDS-PAGE gel followed by
western blot. The blot was blocked with 3% BSA in TBS-T for 1 hour at ambient
temperature. 2 Ftg / mL Streptavidin-HRP conjugate in 3%BSA / TBS-T was applied to
the blot for 15 minutes at ambient temperature followed by three 5-minute washes in
TBS-T to remove unbound streptavidin. The blot was then visualized using Supersignal
West Luminol (Pierce).
Ketone biotinylation and hydrazide conjugation
AP-tagged proteins in 50 mM bicine pH 8.2 with 5 mM Mg(OAc) 2 were treated with 1
!tM BirA, 4 mM ATP, and 200 tM racemic ketone biotin for 3 hours at 30 C. The pH
was then adjucted to 6.2 with 0.1 M HC1 prior to adding 1 mM hydrazide probe. The
reaction was incubated at 30 °C for 12-15 hours before the hydrazide adduct was reduced
by 15 mM NaBH 3CN at 4 C for 1.5 hours. Samples were diluted with protein loading
buffer and heated to 100 C for 15 minutes prior to loading onto 12 % SDS-PAGE.
Fluorescein hydrazide was visualized in-gel by fluorescence scanning on a STORM
fluorescence scanner. BPBio-hydrazide-treated samples were transferred by western blot
and visualized using the same protocol as for the biotinylation assay.
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Crosslinking Assays
AP-tagged proteins were subjected to the ketone biotinylation and hydrazide conjugation
protocol described above. Following hydrazide conjugation, samples were placed on ice
for 2-30 minute UV irradiation. Following irradiation, the hydrazide conjugate was
reduced and 8% SDS-PAGE performed. BP-hydrazide and BP-linker hydrazide were
visualized by either silver or coomassie staining. BPBio hydrazide samples were detected
by either silver staining or by western blot and streptavidin-HRP detection as described
above.
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Chapter 2:
5(6)-carboxyfluorescein
O
0O 
Trimellitic anhydride (26.5 mmol, 5.09 g) and resorcinol (53 mmol, 5.84 g) Were stirred
overnight at 800C in 80 mL methanesulfonic acid. The resulting red solution was allowed
to cool to room temperature before pouring into 300 mL of ice water with stirring. A
orange-yellow solid precipitated. The solid was collected by filtration and rinsed three
times with water, Drying of the solid at 1100 C or high vacuum resulted in a yellow-
orange solid in near quantitative yield as a near 50-50 mixture of 5- and 6-
carboxyfluorescein. 'H-NMR (300 MHz, DMSO): 6 8.40 (1H, m), 8.30 (1H, dd, J=8.1
Hz, J2 =1.5 Hz), 8.22 (1H, dd, J1=8.1 Hz, J2=1.5 Hz), 8.10 (1H, dd, J1=8.1 Hz, J2=0.6 Hz),
7.66 (1H, m), 7.39 (1H, dd, J=8.1 Hz, J2=0.6 Hz), 6.72-6.52 (12H, m)
Bis-pivanoyl-6-carboxyfluorescein diisopropylammonium salt
c-, r
5(6)-carboxyfluorescein (39.85 mmol, 15 g) was stirred at reflux in a mixture of
trimethylacetic anhydride (159.4 mmol, 30g) and triethylamine (120 mmol, 12 g) and
monitored by TLC (1% AcOH, 5% MeOH in DCM) until a single spot was present. The
solution was cooled room temp followed by the addition of 15 mL water and 15 mL
THF. The solution was stirred vigorously for 2 hours and diluted in 150 mL ether. The
organic layer was washed three times with 1.4 M, pH 7 phosphate buffer, once with 1M
52
I
HCl, and twice with brine. The organic layer was dried over MgSO4 and the solvent
removed in vacuo. The resulting syrup was dissolved into 40 mL EtOH and 20 mL
diisopropylamine and cooled to -200 C. A white solid formed which was collected by
vacuum filtration, washed twice with cold EtOH and once with cold acetone. The sticky
white residue was then dried to a white powder in vacuo. . 'H-NMR (300 MHz, CDC13):
6 8.25 (1H, dd, J=8.1 Hz, J2=1.5 Hz), 7.98 (1H, dd, J1=7.8 Hz, J2=0.6 Hz), 7.68 (1H, m),
7.02 (2H, d, J=2.1 Hz), 6.83 (2H, d, 8.4 Hz), 6.74 (2H, dd, J1=8.7 Hz J2=2.1 Hz), 3.21
(2H, sept, J=6.3 Hz), 1.35 (18H, s), 1.22 (12H, d, J=6.6 Hz)
6-Carboxyfluorescein
>0C° ,0 0)r < HO 0 OH
0 0 1 °HO NNH,' - HO
o 0
Diisopropylammonium Bis-pivanoyl-6-carboxyfluorescein was dissolved in a minimal
volume of methanol followed by the addition of 2M aq. NaOH. A deep red-black color
developed. The solution was stirred until TLC (1% AcOH, 5% MeOH in DCM) showed
complete removal of the pivolate groups. Methanol was removed in vacuo and the
resulting aqueous solution treated with 1M HCl with stirring to precipitate the 6-
cabroxyfluorescein as a voluminous yellow solid. The solid was collected by filtration
and dried under high vacuum to a yellow solid. 'H-NMR (300 MHz, DMSO): 10.18
(bs, COOH), 8.22 (1H, d, J=8 Hz), 8.11 (1H, d, J=8 Hz), 7.65 (1H, s), 6.70-6.53 (6H, m),
3.40 (bs, OH)
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5-carboxyfluorescein
0
0 0
HO C HO O
The pivolate syrup was completely depleted of 6-carboxyfluorescein by repeated
precipitation with diisopropylamine in ethanol at -20 C. The remaining syrup was
dissolved in THF to which 2M aq. NaOH was added. The solution was allowed to stir at
RT as a deep red-black color developed. The solution was stirred until TLC (1% AcOH,
5% MeOH in DCM) showed complete removal of the pivolate groups. THF was removed
in vacuo and the resulting aqueous solution treated with 1M HCl with stirring to
precipitate the 5-cabroxyfluorescein as a voluminous yellow solid. The solid was
collected by filtration and dried under high vacuum to a yellow solid. 'H-NMR (400
MHz, DMSO): 6 10.25 (bs, COOH) 8.40 (1H, d, J=1.6 Hz), 8.29 (1H, dd, J1= 8 Hz, J2=
1.6 Hz), 7.40 (1H, d, J=8 Hz), 6.72 (1H, d, J=2 Hz), 6.61 (1H, d, J= 9Hz), 6.55 (1H, dd,
.J1 = 9 Hz, J2= 2 Hz), 4.21 (bs, OH)
5-carboxyfluorescein dimethyl ester
HO 0 OH 0 0 OH
.. SiCCOOMe
HO O MeO O
5-CF impurities in some 6-CF batches were observed by 1H-NMR to be converting to the
desired dimethyl esters and methyl ethers. As such, an attempt was made to make use of
the stock of 5-CF we have available. 5-CF was refluxed overnight in MeOH with
catalytic sulfuric acid. The resulting solution was concentrated and diluted in DCM,
washed with 100 mM pH 7 phosphate buffer and brine, then dried over MgSO4. Removal
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of the solvent yielded a red solid. H-NMR (CDC13): 8.91 (d, 1H), 8.43 (dd, 1H), 7.48
(d, 1H), 7.23-7.13 (m, 6H), 4.06 (s, 3H), 3.67 (s, 3H)
5-carboxyfluorescein methyl ether
O 0 O OH
COOMe -
MeO O
MeO 0 OH
0
HO O
5-CF Dimethyl ester was dissolved into dry DMF in the presence of Cs2CO3. Mel was
added and the reaction stirred until completion. The solution was diluted in ethyl acetate
and washed with citric acid and brine. The organic layer was dried over MgSO 4 and the
solvent removed in vacuo. 1M NaOH was added along with a minimal amount of
methanol and allowed to stir overnight. The product was re-precipitated using 1M HCl
and collected by filtration. 'H-NMR(MeOD): 6 8.59 (d, 1H), 8.4 (d, 1H), 7.30 (d, 1H),
6.86 (t, 1H), 6.7-6.6 (m, 5H), 3.85 (s, 3H)
6-carboxyfluorescein dimethyl ester
HO N 0 NOH
0
HON
0o
*~,,COOMe
MeO N
0
Purified 6-carboxylfuorescein was refluxed overnight in methanol in the presence
of catalytic sulfuric acid. Following washings and extraction into dichloromethane, the
desired compound was attained in 60-75% yield. H-NMR (300 Mhz, CDC13): 8.32 (s,
2H1), 7.98 (s, H), 6.93-6.77 (m, 6H), 3.94 (s, 3H), 3.65 (s, 3H), 3.24 (bs)
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6-carboxyfluorescein methyl ether
0
ME
OH MeO O OH
)Me ' a
HOS
0
6-carboxyfluorescein dimethyl ester was treated with iodomethane in the presence
of cesium carbonate followed by ester cleavage in 2M NaOH. Precipitation with 1M HCl
yielded the desired compound in about 50% yield. 1H-NMR (300 Mhz, MeOD): 8.30 (d,
LH, J=7.8 Hz), 8.07 (d, 1H, J=7.8), 7.72 (s, 1H), 6.87 (s, 1H), 6.71-6.43 (m, 5H), 3.84 (s,
3H) ESI-MS: [M+H]+ calc. 391.0812 found 391.0813
6-carboxyfluorescein methyl ether dibenzyl phosphate
MeO 0 OH MeO 0 O-P-OBn
OBn
HO N HO
O 0
6-carboxyfluorescein was dissolved in dry acetonitrile under argon with 3 eq. of
dicyanoimidazole. 2 eq. of dibenzyl-diisopropyl-phosphoramidite was added by syringe
and the solution stirred at RT for 45 min. The resulting phosphite was oxidized by the
portion-wise addition of 4 eq. mCPBA and stirred at RT for an additional 30 min. The
solution was diluted with DCM, washed sequentially with 1.5 M Na2SO 3, 1M HCl, and
brine followed by drying over Na2SO4. The solution was concentrated in vacuo and
purified over silica using a gradient of 0% to 5% MeOH in DCM with 1% AcOH. . H-
NMR (400 MHz, CDC13): 6 8.35 (1H, d), 8.13 (1H, d), 7.85 (1H, s), 7.34 (10OH, m), 7.08
(1H, s), 6.68 (2H, m), 6.67 (3H, m), 5.16 (4H, dd), 3.86 (1H, s)
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6-carboxyfluorescein methyl ether dibenzyl phosphate N-hydroxysuccimidyl ester
o Q
MeO 0 O-P-OBnMeO i0 "O-P-OBn
6 Bn ABn
HO - 0
HO 0
6-carboxyfluorescein methyl ether dibenzyl phosphate was dissolved in DCM with 2 eq.
N-hydroxysuccinimide and 1.2 eq. EDC-HCl and stirred at RT. The reaction was
monitored by TLC (EtOAc) with additional NHS and EDC-HCl added until completion
0.5 eq at a time. The solution was diluted with DCM, washed with brine, and dried over
Na2SO 4. The product was purified over silica (50% to 100% EtOAc in hexanes) and dried
under high vacuum. Rf = 0.76 in EtOAc. 1H-NMR (300 MHz, CDC13): 8.39 (1H, dd,
J 1= 8Hz J2= 1 Hz), 8.16 (1H, d, J= 8 Hz), 7.88 (1H, s), 7.32 (1OH, m), 7.10 (1H, s), 6.78
(2H, m), 6.66 (3H, m), 5.13 (4H, dd, J= 9 Hz, J2= 1 Hz), 3.86 (3H, s), 2.89 (4H, s)
6CFME-PhosOH2
o O
MeO ' O-P-OBn MeO n O--OH
Bn 6H
HO N HO
O 0
6NHS-CFME-Phos-OBn2 was added to an oven-dried round bottom flask with stirbar.
The flask was evacuated and refilled with argon four times followed by the addition of
DCM distilled fresh over CaH2. 10 eq. of TMS-Br was then added by syringe and stirred
at RT. A deep brown color developed almost immediately. At 2 hours, the reaction was
diluted with DCM and extracted with water. The aqueous layer was washed with DCM
prior to solvent removal in vacuo to provide the product as a faint yellow solid. The solid
was tested against alkaline phosphotase and recognized by the enzyme.
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6NHS-CFME-PhosOH2
o O
MeO 0 O-P-OBn MeO O, i O-P-OH
i" I Bn I I
o 0
c % ~ o
O 0
6NHS-CFME-Phos-OBn2 was added to an oven-dried round bottom flask with stirbar.
The flask was evacuated and refilled with argon four times followed by the addition of
DCM distilled fresh over CaH2. 10 eq. of TMS-Br was then added by syringe and stirred
at RT. A deep brown color developed almost immediately. At 2 hours, the reaction was
diluted with DCM and extracted with water. The aqueous layer was washed with DCM
prior to solvent removal in vacuo to provide the product as a faint yellow solid. The solid
was tested against alkaline phosphotase and recognized by the enzyme.
5C-TPF-OEt2
HO 0 O-P-OEt
I 0
Nh w,
mu 
5-carboxyfluorescein was dissolved in dry DMF and cooled in an ice bath. 4 eq. of NaH
was added in portions and the reaction stirred on ice until gas evolution ceased. 2.2 eq of
chloro-diethyl-thiophosphate was then added and the solution brought to RT. The
reactionw as diluted with DCM, washed with water and brine, and dried over Na2SO4.
The product was purified over silica using 0% to 5% MeOH in DCM with 1% AcOH.
TLC with 5% MeOH and 1% AcOH in DCM produced a single spot at Rf= 0.8. 'H-NMR
(400 Mhz, CDC13) 8.71 (1H, s), 8.36 (1H, d, J = 8 Hz), 7.27-6.56 (7H, m), 4.28-4.20
(4H, m), 1.42-1.35 (6H, m) 31P-NMR (161 Mhz, CDC13) 62.8 ESI-MS: 529.1 [M+H] +
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5NHS-TPF-OEt2
HO 0 , O-P-OEt
6Et
- 0
5C-TPF-OEt2 was dissolved in acetonitrile followed by the addition of 2 eq. NHS and 2
eq. EDC-HCI. The solution was stirred for 3 hours before being diluted with DCM,
washed with water and brine, and dried over Na2SO4. Purification was done by silica
column using a gradient of 0% to 5% MeOH in DCM with 1% AcOH to provide a yellow
solid.. 'H-NMR (400 Mhz, CDC13) 6 8.73 (1H, s), 8.34 (1H, d, J = 8 Hz), 7.32-6.52 (7H,
m), 4.25-4.20 (4H, m), 2.93 (4H, s), 1.37-1.34 (6H, m) 3 1 P-NMR (161 Mhz, CDC1 3) 
62.7 ESI-MS: 626.2 [M+H]+
6C-TPF-OBn2
S
MeO 0 , O-P-OBn
6Bn
HO,
n
6CFME and 3 eq. DCI were combined in an oven-dried flask with stirbar. The flask was
evacuated and refilled with dry argon 3 times. Freshly distilled, dry acetonitrile was
added by syringe followed by 2 eq. dibenzyl-diisopropyl-phosphoramidite. The solution
was stirred for 30 minutes at which point ESI-MS (pos. mode) showed a single peak
corresponding to a phosphite product at m/z 635 [M+H]+. The flask was opened briefly to
add 6 eq. elemental sulfur and stirred at RT overnight. The phosphite gradually vanished
as the thiphosphate peak appeared at m/z 677 [M+H]+ . The reaction was diluted with
DCM, washed with water and brine, and dried over MgSO4. The solvent was removed in
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vacuo, the residue suspended in acetonitrile, and the solids removed by centrifugation.
The supernatant was purified by reverse phase semi-preparative HPLC using a gradient
of 25% to 85% acetonitrile in water with 0.1% TFA over 20 minutes with a flow of 4.7
mL / min. The product eluted at 19 min as monitored by absorbance at 254 nm. The
product was lyophilized to an reddish-orange oil. 1H-NMR (300 Mhz, CDC13) 6 8.34
(1H, dd, J= 8 Hz, J2= 1 Hz), 8.12 (1H, d, J= 8 Hz), 7.87 (1H, s), 7.35-7.30 (10H, m),
7.06 (1H, s), 6.80-6.65 (5H, m), 5.20-5.16 (4H, m), 3.85 (3H, s) 31P-NMR (121 Mhz,
CDC1 3) 6 63.7
6NHS-TPF-OBn2
0 oMeO_<,OBn 
HO > QN n
6C-TPF-OBn2 was dissolved in DCM with 1.4 eq. NHS at RT. 1.4 eq. EDC-HCl was
then added and the reaction stirred for 3 hours. ESI-MS showed complete conversion to
product. The reaction was diluted with DCM, washed three times with brine, and dried
over Na2SO4. The solvent was removed in vacuo and the residue dissolved in acetonitrile
for HPLC purification as described for 6C-TPF-OBn2 with an elution time of 21 min. 'H-
NMR (400 Mhz, CDC13) 6 8.40 (1H, dd, J1= 8 Hz, J2= 1 Hz), 8.17 (1H, d, J= 8 Hz), 7.92
(IH, s), 7.35-7.30 (10H, m), 7.08 (1H, s), 6.80-6.65 (5H, m), 5.20-5.16 (4H, m), 3.86
(3H, s), 2.88 (4H, s)
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6NHS-TPF
S
MeO 0 O-P-OH
I OH
N'
6NHS-TPF-OBn2 was dissolved in dry acetonitrile under argon. 20 eq. TMS-Br was
added by syringe and the solution heated to 55 °C for 2 hours. The reaction was quenched
with MeOH and the crude purified by semi-prep HPLC under the same conditions as 6C-
TPF-OBn2 with elution times of 9 min. corresponding to the fully deprotected product
and 12 min. for the mono-benzylated product. Both compounds were flash frozen and
lyophilized to yellow solids.
Alkaline phosphatase assay
100 tM FDP or 16 FtM 6CFME-phosphate were monitored at 30 °C in 50 mM
Tris-HCl pH 8.0 supplemented with 25 mM MgCl 2 on a SAFIRE plate reader in the
presence or absence of 0.1 unit CIP. Excitation at 490 nM with monitoring from 495-550
nM in 5 nM increments and a 5 nM emission bandwidth. Fluorescence measurements
were taken from the bottom of a 96 well plate at 60 second intervals for 60 minutes.
RNA translation and purification
1 g of the library template (2 x 1013 molecules) was used in a 20 tL RNA
trancription reaction using an Ampliscribe T7-Flash kit according to manufacturer's
instructions. The reaction was conducted at 42 °C for 1 hour prior to purification on a 7%
PAGE-Urea gel. RNA was located within the gel by UV shadowing against a silica plate
and excised. The RNA-containing gel fragment was crushed and allowed to equilibriate
with DEPC-treated water for 6 hours at 4 °C. The RNA was ethanol precipitated and
resuspended in RNA binding buffer (50 mM Tris-HCl pH 8, 50 mM NaCl, 50 mM KCl).
Library activity assays
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Fluorescein diphosphate (FDP), 6,8-difluoro-4-methylumelliferyl phosphate
(DiFMUP), and 9H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl) phosphate (DDAO)
were obtained from Molecular Probes, and stock solutions were prepared according to
their instructions. 6CFME-phosphate was prepared as a 10 mM stock solution in 50 mM
Tris-HCl pH 7.4. RNA activity assays were conducted with the commercial probes in 50
mM Tris-HCl pH 7.4 in the presence or absence of 25 mM MgCl 2 at 30 C. 6CFME-
phosphate assays were conducted under the same conditions except that the pH was set to
8.0. FDP and 6CFME-Phosphate were exited at 490 nM and fluorescence monitored from
495-530 nM in 5 nM increments with a 2.5 nM emission bandwidth. DDAO was excited
at 646 nM and monitored from 650-670 nM in 5 nM increments with a 2,5 nM emission
bandwidth. DiFMUP was excited at 358 nM and monitored from 435-475 nM in 5 nM
increments with a 2.5 nM emission bandwidth. All probes were used at a final
concentration of 100 tM. Positive controls to show full fluorescence turn on were treated
with 0.1 unit of calf intestinal phosphatase (New England Biolabs). 1 tg RNA was used
per 25 [tL reaction. Reactions were run in clear, flat bottomed 96 well plates and sealed
with clear tape. Fluorescence measurements were taken from the bottom of the well at 1-
2 minute intervals with orbital shaking (10 seconds shaking, 5 seconds settle time)
between each measurement using a SAFIRE plate reader.
Aptamer Selection Protocol
Both negative and positive selection beads were pre-blocked with 3% BSA in
RNA binding buffer (50 mM Tris-HCl pH 8.0, 50 mM NaCl, 50 mM KCl) for 20 minutes
at 37 °C. The beads were spun down and washed twice with binding buffer. To 0.5 mg of
pre-blocked negative selection beads, 0.2 nmol of the RNA library was applied in binding
buffer. The RNA was incubated for 15 minutes at 37 C and the beads removed by
centrifugation. The supernatant was then applied to 0.5 mg of pre-blocked positive
selection beads in for 30 min at 37 °C. The beads were spun down and washed 4 times
with binding buffer containing 3% BSA and 0.1% Tween followed by 2 more washes
with binding buffer alone. Bound RNA was eluted using 100 tM 6-carboxyfluorescein
methyl ether phosphate in binding buffer at 37 °C for 15 min. The beads were removed
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by centrifugation and RNA ethanol precipitated to remove fluorescein. The RNA was
then converted back to DNA with the addition of a T7 promotor by RT-PCR using the
primers 5'- GGATTTCGAAAGCCAGCTTAATGAGCAACG and 5'-
AGCGGGTACCGCGTAATACGACTCACTATAGGAGTGGTTGCATGTACGCC. The RT-PCR
cycle consisted of 1 30 minute RT reaction at 50 °C, 2 min at 94 °C, followed by 40
cycles of 15 sec 94 °C, 15 sec 64 °C, and 30 sec 66.5 °C. The product was either ethanol
precipitated or purified using a Qiagen PCR cleanup kit.
Library Cloning
Both the library and pUC19 were sequentially digested overnight by KpnI followed by
Csp45I. The resulting fragments were purified by agarose gel and extracted from the gel
using a Qiagen gel extraction kit. Vector and insert were ligated using T4 DNA ligase
and transformed into E. coli strain DH5a. Single colonies were chosen and grown in LB
broth supplemented with ampicillin to saturation, and the plasmids isolated using a
Qiagen miniprep kit. Plasmids were analyzed by analytical digest and sequencing.
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Chapter 3:
3'0, 5'0-TIPDS-Adenosine
NH2
N NH2
1 .'I r O N i N
HOC bOH S
1.1 eq of 1,3-dichloro-1,1,3,3-tetraisopropyl-disiloxane was added to a suspension of
adenosine in dry pyridine under argon and stirred at RT overnight. The solvent was
removed in vacuo and the residue dissolved in DCM. The organic layer was washed with
sat. NaHCO3 and the aqueous layer extracted twice with DCM. The combined organic
phases were dried over Na2SO4 and concentrated in vacuo. The resulting syrup was
purified over silica (0% to 5% MeOH in DCM) and dried under vacuum to yield a dense,
white solid. . 1H-NMR (300 MHz, CDC13): 8.28 (1H, s), 7.97 (1H, s), 5.98 (3H, bs),
5.09-5.04 (1H, m), 4.58 (1H, d, J= 6 Hz), 4.17-4.00 (3H, m), 3.76 (1H, bs), 1.12-0.98
(28H, m)
N, N, 2'0-tribenzoyl, 3'0-5'0-TIPDS Adenosine
NH2 N NBz2N . I .
,O OBz
-s'i
To a solution of TIPDS-Adenosine in pyridine was added 5 eq of Bz-Cl. The solution
was allowed to stir at RT for 16 hours prior to the addition of water. The mixture was
stirred for an additional 30 minutes and then had the solvent removed in vacuo. The
resulting material was dissolved in DCM and washed with saturated sodium bicarbonate
and dried over magnesium sulfate. Purification over silica column using 1:1, 2:1, 1:0
ethyl acetate/hexanes produced the desired product as a white foam. Yields are nearly
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quantitative. 1H-NMR (CDC13) 6 8.60 (s, 1H), 8.23 (s, 1H), 8.1 (m, 2H), 7.87 (m, 4H),
7.6 (m, 1H), 7.46 (m, 4H), 7.37 (m, 4H), 6.2 (s, 1H), 6.08 (d, 1H, J=4), 5.25 (m, 1H),
4.19-4.09 (m, 3H), 1.27-1.07 (m, 21H), 0.95-0.83 (m, 7H) ESI-MS: calc. 821.3 found
821.4
N6,N6, 2'0-tribenzoyl adenosine
No  NBz2
Vo- -N N o Nbxz HO< NC\ 'OB Ho(H bBz
HO' 'OBz
Several sets of cleavage conditions using various amine/HF and TBAF/THF systems
were attempted. A dilute solution of 4:1 (v/v) TEA/HF in acetonitrile was found to cleave
the silyl group completely within 1 hr at RT. The solution was then diluted with DCM
and washed with 5% ammonium hydrogen carbonate to neutralize and remove remaining
TEA/HF. Purification by silica column using 2:1, 1:1, 1:2 hexanes/ethyl acetate. H-
NMR (400 Mhz, CDC13): 6 8.59 (s, 1H) 8.19 (s, 1H), 8.11-8.09 (m, 2H), 7.87-7.85 (m,
4H), 7.64-7.60 (m, 1H), 7.53-7.46 (m, 4H), 7.36-7.35 (m, 4H), 6.02 (d, 1H, J=7.6), 5.68
(d, 1H, J=5.6), 5.21 (dd, 1H, J=7.6, 5.2), 4.51 (s, 1H), 4.01-3.90 (m, 2H) 3 C-NMR (125
Mhz, CDC13): 172.5, 166.4, 152.8, 151,152.0, 151.7, 145.2, 133.9, 133,5, 130.0, 129.7,
129.3, 129.1, 129.0, 128.8, 127.5, 91.3, 86.1, 75.3, 73.3, 63.1 ESI-MS: calc. 579.2 found
579.2
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5' O-(t-butyl-dimethylsilyl)-N6,N 6, 2' O-tribenzoyl-adenosine
N NBz 2
X7 SiO-5o N N
HO "OBz
N6,N6 , 2'0-tribenzoyl adenosine was dissolved in dry DMF under argon to which a
freshly prepared solution of 1M TBDMS-Cl and 2M imidazole was added by syringe 1
eq at a time. The solution was stirred at RT overnight with additional TBDMS-Cl /
imidazole solution added until completion was reached as determined by TLC. The
solution was diluted with ethyl acetate and washed with brine several times. The organic
phase was dried over Na2SO4 and concentrated in vacuo. The resulting syrup was purified
over silica (0% to 33% ethyl acetate / hexanes). Rf (2:1 EtOAc / Hexanes) = 0.82 'H-
NMR (500 Mhz, CDC13): 6 8.65 (1H, s), 8.42 (1H, s), 8.15-8.13 (2H, m), 7.89-7.87 (4H,
m), 7.64 (1H, m), 7.52-7,49 (4H, m), 7.40-7.36 (4H, m), 6.23 (1H, d, J=7 Hz), 5.67 (1H,
dd, J1= 5.5 Hz, J2 = 1.5 Hz), 4.99 (1H, dd, J = 7 Hz, J2= 5.5 Hz), 4.52 (1H, dd, J = 4 Hz,
J2 = 2.4 Hz), 3.95 (2H, m), 0.84 (9H, s), 0.09 (3H, s), 0.03 (3H, s) ESI-MS: calc 693.3
found 694.4
TBS-TBA-Phosphoramidite
N~~~z 0~~ NBz
0 N ~ ~ ~ ~ . bN
+-Si-O, NA .0I .'_OBzN
HO >OBz X,N OMe
TBDMS-TBA and 2 eq. DCI were sealed in a dry flask with stirbar. The flask was
evacuated and refilled with argon five times after which dry DCM was added by syringe
and 2 eq. (iPr2N)2POMe. The reaction was stirred at RT and monitored by TLC (1:1
EtOAc / hexanes) with the product appearing at Rf = 0.79 and starting material at Rf =
0.32. Upon completion, the reaction was diluted with DCM, washed briefly with water to
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remove the activator and dried over Na2SO4. Purification over silica using a gradient of 0
to 20% EtOAc in hexanes provided the product diastereomers as a colorless oil that
foamed under vacuum. 'H-NMR (300Mhz, CDC13) 6 8.69 (1H, d, J=6 Hz), 8.44 (1H, d,
J=8 Hz), 8.16-8.10 (2H, m), 7.90-7.87 (4H, m), 7.64-7.57 (1H, m), 7.52-7.44 (4H, m)
7.39-7.33 (4H, m)6.43-6.36 (1H, m), 5.70-5.63 (1H, m), 5.12-5.00 (1H, m), 4.45-4.42
(1H, m), 4.01-3.98 (2H, m), 3.45-3.32 (2H, m), 3.18 and 2.90 (combined 3H, both d, J=
13 Hz), 1.00-0.81 (21H, m), 0.16-0.12 (6H, m)
6CFME-TBS-TBA
N NBz2I ,
.. OBz
, N'P OMe
I-
TBS-TBA-phosphoramidite, was sealed in a dry flask with 2 eq. DCI and 1.5 eq. 6CFME
under dry argon. Dry, freshly distilled acetonitrile was added by syringe and the reaction
stirred at RT for 30 min. The flask was then opened and 3 eq. of mCPBA added to
oxidize the phosphite intermediate. After 30 min of oxidation, the solvent was removed
in vacuo and the residue dissolved in DCM. The organic layer was washed with 1.5 M
Na2SO3, 1M HC1 and brine, then dried over Na2SO4. The crude mixture was purified over
silica using 0-100% distilled THF in hexanes to provide an orange oil. 'H-NMR (500
Mhz, CDC13) 6 8.69-8.63 (1H, m), 8.51-8.49 (1H, m), 8.32-8.20 (3H, m), 7.86-7.82 (4H,
m), 7.60-7.51 (1H, m), 7.47-7.41 (4H, m), 7.36-7.33 (4H, m), 6.74-6.50 (6H, m), 5.80-
5.70 (2H, m), 4.49 (1H, m), 4.05-3.95 (2H, m), 3.85-3.82 (3H, m), 3.67-3.64 (1H, m),
3.58-3.55 (1H, m), 0.93-0.91 (9H, m), 0.13-0.11 (6H, m)
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TIPDS-N 6-benzoyl adenosine
N NBz2
' ___ / OBz
61'r
TIPDS-TBA (800 mg) was dissolved in 25 mL EtOH at 0 °C followed by the
addition of 5 mL 25% (w/v) NaOMe / MeOH. The reaction was stirred on ice for 30
minutes before the reaction was terminated by the addition of 2 mL pyridine and 2 mL of
glacial acetic acid to form a white slurry. The solvent was removed in vacuo and the
residue dissolved in DCM. The organic layer was washed sat. NaHCO 3, and the aqueous
layer was back-extracted twice with DCM. The combined organic layers were dried over
MgSO4 and purified over silica using a gradient of 0% to 4% MeOH in DCM. Removal
of the solvent in vacuo yielded a white solid. 1H-NMR (300 Mhz, CDC13): b 9.00 (s, 1H),
8.76 (s, 1H), 8.15 (s, 1H), 8.02 (d, 2H, J=7.2 Hz), 7.66-7.48 (m, 3H), 6.04 (s, 1H), 5.14
(dd, 1H, J=7.8, 5.4), 4.62 (d, 1H, J=5.4), 4.16-4.03 (m, 3H), 3.21 (s, 1H), 1.15-1.02 (m,
28H)
3' 0-5' 0-TIPDS-2'-6CFME-Adenosine
N NHBz N
S O
Si dc> H
TIPDS-N 6-benzoyl adenosine and 2.6 eq. 4,5-dicyanoimidazole were combines in a dry
flask with stirbar purged and filled with argon. Dry acetonitrile was added by syringe and
the solids dissolved prior to the addition of 2.6 eq. (iPr 2N) 2POMe. The reaction stirred at
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RT for 1 hour when TLC (EtOAc) showed complete consumption of the starting material.
The solvent was removed in vacuo and the residue filtered through a silica plug with 1:1
EtOAc / hexanes to remove the activator and most of the phosphorodiamidite. The
product was dried under vacuum prior to addition of 2.6 eq. DCI and 2 eq. 6CFME. The
flask was purged with argon and dry acetonitrile was added by syringe. The solution
stirred at RT for 1.5 hours before a solution of 5 eq. mCPBA in acetonitrile was added by
syringe. Oxidation was allowed 40 minutes for completion before the solvent was
removed in vacuo. The residue was dissolved in EtOAc, washed with 1.5M Na2SO3, 1M
HCl, and brine and dried over Na2SO4.
2'-ACE-benzoyl adenosine
NHBz N NHBz
N 0 
o N HO N<A YOir Nd 
TIPDS-benzoyl adenosine was treated with ACE orthoester and catalytic PPTS
under hi vacuum at 55 C. PPTS was removed after neutralization with TMEDA by
running the solution over a small column of silica with 1:1 EtOAc/Hexanes. Removal of
solvent followed by treatment with 9:1 TMEDA/HF in acetonitrile to cleave the silyl
groups yielded the desired product in 65% yield (2 steps)
'H-NMR (300 Mhz, CDC13): 6 9.25 (bs, 1H), 8.76 (s, 1H), 8.08 (s, 1H), 8.03 (d, 2H,
.J=8.7 Hz), 7.62-7.43 (m, 3H), 6.00 (d, 1H, J=7.5 Hz), 5.21 (s, 1H), 5.09 (dd, 1H, J=7.2,
4.8 Hz), 4.51 (d, 1H, J=4.8 Hz), 4.23-4.15 (m, 1H) 4.07-3.42 (m, 11H), 2.06-2.02 (m,
6H) ESI-MS: calc. 589.2020 found 589.2009
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5'TBS-2'ACE-benzoyl adenosine
NHBz NHBz
IHO <NN -Si-OO N'
0 / HO O>_Hd 0 H O'
0 0
2'Ace-adenosine was reacted with 2 eq of imidazole and 1.1 eq of TBS-Cl in dry
DMF. After stirring at room temperature overnight, a new spot on TLC appears at Rf=0.5
in 5% MeOH in EtOAc. This is of higher mobility than the starting material which near
RI-0.25. The reaction mixture was washed twice with water and once with brine, then
dried over MgSO4. Column purification yielded two fractions: one with Rf0.5 and one
that corresponds to recovered starting material. Obtained product in 37% yield and
recovered 34% starting material. 1H-NMR: (ppm) 9.15 (bs, 1H), 8.80 (s, 1H), 8.40 (s,
1H), 8.03 (d, 2H), 7.55 (dt, 3H), 6.32 (d, 1H), 5.40 (s, 1H), 4.87 (t, 1H), 4.43 (q, 1H),
4.23-3.47 (m, 11H), 3.02 (bs, 1H), 2.02, (d, 6H), 0.92 (s, 9H), 0.12 (d, 6H)
5'TBS-3' diisopropyl methoxyphosphoramidite-2'ACE-benzoyl adenosine
NNHBz NHBz
, N 0N 0\_)Si.O' .N jN
HO' O O. OMeO-P, /"O o'
NP< 011
0 0
5'TBS-2'ACE-benzoyl adenosine was combined with dicyanoimidazole (1 eq) in
a dry round bottom flask and sealed with a rubber septum. The flask was placed under hi-
vac for 30 minutes followed by 5 fill-purge cycles with nitrogen. 1 mL of freshly distilled
dry DCM was then added by syringe followed by tetraisopropyl methoxy
phosphordiamidite. The reaction was allowed to stir at room temperature and was
monitored by TLC using 2:1 EtOAc/Hexanes. The solvent was removed in vacuo and the
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compound purified over silica using 1:1 EtOAc/Hexanes. Overnight drying on hi-vac
yielded a clear oil in 28% yield..
'H-NMR: (ppm) 9.06 (bs, 1H), 8.80 (s, 1H), 8.41 (s, 1H), 8.03 (d, 2H), 7.56 (dt, 3H),
6.33 (m, 1H), 5.46 (s, 1H), 4.9-3.8 (m, 18H), 2.01 (d, 6H), 1.25-1.17 (m, 12H), 0.94 (9H),
0.11 (6H) 31P-NMR: 6 (ppm) 148
TIPDS-THP-NBz-Adenosine
NHBz N NHBz
o °'<OH O'Si r
TIPDS-NBz-Adenosine (500 mg, 0.81 mmol) was dissolved in DCM with TsOH (154
mg, 0.81 mmol). Dihydropyran (274 mg, 3.26 mmol) was then added and the solution
stirred at RT for 6 hours at which point ESI-MS showed complete consumption of the
starting material. The reaction was diluted with DCM, washed with sat. NaHCO3 and
brine, and dried over Na2SO4. The crude product was purified over silica using 0% to 2%
MeOH in DCM to yield an oil in quantitative yield. H-NMR (300 Mhz, CDC13) 9.16
(1H, s), 8.77 and 8.74 (1H, s), 8.35 and 8.23 (1H, s), 8.01 (2H, d, J=7 Hz), 7.58-7.47 (3H,
m), 6.14 and 6.10 (1H, s), 5.32-3.49 (8H, m), 1.88-1.40 (6H, m),1.09-0.97 (28H, m) ESI-
MS [M+H] + 698.3
THP-NBz-adenosine
NHBz NHBz
> Nr NN J
O 'O/ O° °H  O
TIPDS-THP-NBz-Aden (350 mg, 0.5 mmol) was dissolved in 4 mL acetonitrile in a
polypropylene tube followed by the addition of 0.5 mL 4:1 (v/v) TEA/HF. The reaction
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'was monitored by TLC (5% MeOH / EtOAc) for 4 hours at RT. The reaction was then
diluted with DCM, washed with 5% NH4HCO3 and brine, and dried over Na2SO4. The
crude was purified over silica using 50% to 100% EtOAc in hexanes followed by 5%
MeOH in EtOAc to elute the product as an off-white solid in 44% yield.. 'H-NMR (400
Mhz, CDC13) 6 8.81 (1H, s), 8.09 (1H, s), 8.05 (2H, dd, Ja = 7 Hz, Jb = 2 Hz), 7.62 (1H, t,
J = 7 Hz), 7.54 (2H, dt, Ja = 8 Hz Jb = 2 Hz), 6.04 and 5.99 (1H, d, J= 7 Hz), 5.11 and
4.89 (1H, dd, Ja = Jb = 8 Hz), 4.6-4.56 (1H, m), 4.43-4.38 (2H, m), 4.03 and 4.02 (1H, s),
3.80 (1H, t, J= 11 Hz), 3.50-2.95 (2H, m), 1.85-1.60 (2H, m), 1.55-1.32 (4H, m) ESI-MS
[M+H]+ 456.2
TBS-THP-NBz-Adenosine
N NHBz NHBz
HO~<jAN NS N
H5O O HO O
THP-NBz-Adenosine (55 mg, 0.12 mmol) was dissolved in 5 mL dry DMF under argon.
0.15 mL of a freshly prepared solution of 1M TBDMS-Cl and 2M imidazole in dry DMF
was added by syringe and the reaction stirred at RT overnight. ESI-MS showed both
product and starting material peaks. An additional 0.2 mL of the TBDMS-Cl/imidazole
solution was added each hour until completion. The reaction was diluted with EtOAc,
washed with water and brine, and dried over Na2SO4. Purification over silica using a
gradient of 0% to 100% EtOAc in hexanes provided the product in 96% yield. H-NMR
(500 Mhz, CDC13) 6 8.83 and 8.82 (1H, s), 8.46 and 8.39 (1H, s), 8.04 (2H, dd, Ja = 7 Hz
Jb = 2 Hz), 7.60 (1H, t, J = 8 Hz), 7.52 (2H, d, J=8 Hz), 6.39 and 6.28 (1H, d, J = 6 Hz),
4.84-3.15 (8H, m), 1.84-1.31 (6H, m), 0.94 and 0.93 (9H, s), 0.13-0.11 (6H, m) 13C-NMR
(125 MHz, CDC13) 6 152.8, 151.8, 149.6, 141.9, 141.6, 133.9, 133.0, 129.0, 128.1, 123.3,
123.1, 101.7, 99.9, 87.2, 86.8, 85.7, 85.5, 82.5, 79.9, 70.7, 70.2, 65.4, 63.4, 63.3, 63.1,
31.0, 30.4, 26.2, 25.0, 21.0, 19.6, 19.4, 18.7, 18.6, -5.10, -5.14, -5.29, -5.30 ESI-MS
[M+H]+ 570.3
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6CFME-TBS-THP-NBz-Adenosine
NHBz
HOG "O,
N NHBz
si-Oe J
MeO-P -
--(--rP
NHBzN I0. Si 0 N(I0.p' 'o o
0 Me
HOARD
II0
TBS-THP-NBz-Adenosine (250 mg, 0.44 mmol) was combined with DCI (104 mg, 0.88
mmol) in a dry flask with stirbar. The flask was evacuated and refilled with argon four
times to remove oxygen and atmospheric moisture. Dry acetonitrile (10 mL) was added
by syringe and the solution stirred at RT to dissolve the solids. (iPr 2N) 2POMe (288 mg,
1.1 mmol) was then added by syringe. Reaction progress was monitored by ESI-MS with
comple consumption of starting material observed at 15-20 minutes. The solvent was
then removed in vacuo, the residue filtered through a silica plug using 1:1 EtOAc /
hexanes, and dried under vacuum to a white foam. 6CFME (242 mg, 0.63 mmol) and
DCI (104 mg, 0.88 mmol) were added and the flask purged with nitrogen. Dry
acetonitrile (10 mL) was added by syringe and the reaction stirred at RT. At 40 minutes,
complete consumtion of the phosphoramidite was confirmed by ESI-MS. The phosphite
was oxidized to the phosphate by the addition of mCPBA (430 mg, 1.76 mmol, 70% by
mass) and stirring at RT for 20 min. The product was purified by semi-prep HPLC using
a gradient of 25% to 85% acetonitrile in water and monitored at 254 nm. The product
eluted at 18 min. ESI-MS [M+H] + 1036.3
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6CFME-TBS-THP-NBz-Adenosine-POMe
NHBz
0 O
Q.PO 'yO
MeO o o CVOMe K
HON
0
NHBz
MeO 0 NOa KJ
HO N'
0
The starting material was dissolved in DMF containing 1M disodium-2-carbamoyl-2-
cyanoethylene-l,1-dithiolate trihydrate (S2Na2) and stirred at ambient temperature for 2
hours. The solution was then diluted with 1:1 acetonitrile / water and purified by reverse-
phase HPLC using a gradient of 25% to 85% acetonitrile in water over 20 minutes with a
flow rate of 4 mL / min. The elution of the compound was monitored by UV absorbance
at 254 nm and appeared with an elution time of 14 minutes. The product was then
lyophilized to an off-white powder. ESI-MS [M+H]+ 1022.3
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H-'H COSY of 6CFME-5' 0-TBS-3'0-THP-N 6 Bz-Adenosine
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Expansion of H-'H COSY of 6CFME-5'-TBS-3'-THP-N Bz-Adenosine
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